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ABSTRACT 
 The recent surge in Type 2 Diabetes (T2D) has renewed interest in the 
study of cellular metabolism – which mitochondria tightly control. Previous work 
has shown mitochondrial dysfunction plays a critical role in the development of 
metabolic diseases, such as T2D. The pancreatic β-cell synthesizes and secretes 
insulin in vivo in response to diverse fuel signals such as glucose, fatty acids, and 
amino acids; failure or loss of β-cell mass is a hallmark of T2D. Pancreatic β-cell 
mitochondria are dynamic organelles living a life of fusion, fission, and movement 
collectively called mitochondrial dynamics. Mitochondrial fusion is impaired in 
obesity and models of obesity, while basal secretion of insulin is elevated. Previous 
studies demonstrate that hyperinsulinemia alone is sufficient to induce insulin 
resistance, yet the relationship between mitochondrial morphology and basal 
insulin secretion has not yet been studied. Here, we investigated the link between 
loss of mitochondrial fusion and insulin secretion at basal glucose concentrations 
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by reducing the expression of mitofusin 2 (Mfn2), which controls mitochondrial 
morphology and metabolism.  We found that forced mitochondrial fragmentation 
caused increased insulin secretion at basal glucose concentrations. In addition, 
fragmentation of mitochondria enhanced the secretory response of islets to 
palmitate at nonstimulatory glucose concentrations and increased fatty acid uptake 
and oxidation in a cell model of pancreatic β-cells.  We developed unique solutions 
to challenges posed by the measurement of mitochondrial dynamics via confocal 
microscopy by using novel image analysis techniques, including a novel method 
of mitochondrial segmentation. This technique also revealed novel biology of 
brown adipose tissue mitochondria dependent on their localization within the cell. 
Our findings demonstrate that changes to mitochondrial dynamics in the β-cell can 
lead to increased insulin secretion at basal glucose concentrations. These data 
support the possibility that hyperinsulinemia and the downstream outcome of 
insulin resistance can be initiated by altered mitochondrial function in the β-cell 
independently of other tissues. By uncovering a new process that governs basal 
insulin secretion, we provide novel targets for regulation, such as mitochondrial 
morphology or fatty acid induced insulin secretion that may present new 
approaches to treatment of diabetes. 
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CHAPTER ONE: General Introduction 
 The prevalence of obesity and T2D is increasing at an alarming rate 
nationally and worldwide, even among young patients (Geiss et al., 2014; 
Imperatore et al., 2012). The financial burden of T2D is increasing accordingly, and 
an effective cure remains elusive, except in the case of bariatric surgery 
(Nannipieri et al., 2011, 2013). T2D is a metabolic disease at its core; the affected 
patient is unable to properly respond to and metabolize nutrient challenges, such 
as ingestion glucose. Systemically, T2D is characterized by uncontrolled glycemia 
resulting from either loss of insulin secretion capacity or loss of tissue response to 
insulin signals in the bloodstream. 
Development of T2D 
Insulin is one of the signals of plenty; its primary functions are suppression 
of glucose production in the liver (Perry et al., 2015; Titchenell, Lazar, & Birnbaum, 
2017) and regulation of energy storage in muscle and adipose (Jensen, Caruso, 
Heiling, & Miles, 1989; Nicholls et al., 2010; Scherer et al., 2012). These roles are 
impeded when the insulin responsive tissues cease responding to normal levels of 
insulin and place increased demand on pancreatic β-cells.  A main focus of this 
work centers on an alternative hypothesis suggesting that hyperinsulinemia 
causes insulin resistance (Corkey, 2012).   
Insulin was first isolated in 1922 by Banting and Best (Karamitsos, 2011) 
and is now known to control circulating and stored nutrient regulation, particularly 
glucose. Glucose metabolism is aerobic or anaerobic, with aerobic oxidation 
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requiring mitochondrial involvement. Glucose is largely consumed by the brain, 
which requires a ~5mM concentration of glucose in the blood (Wasserman, 2009), 
demonstrating the need for such tight regulation. Glucose is also consumed by 
muscle, either through oxidation or storage as glycogen. Muscle uptake of glucose 
is strongly activated by insulin, and loss of insulin sensitivity plays a major role in 
the hyperinsulinemia observed in prediabetic and obese subjects (Kahn, 2003). An 
additional arm of insulin resistance occurs in the liver, where insulin is unable to 
suppress gluconeogenesis (Perry et al., 2015; Titchenell et al., 2017) upon 
development of insulin resistance. Insulin resistance occurs in multiple tissues and 
is difficult to tease apart from the coincident compensatory increased insulin 
secretion from β-cells. 
One hypothesis suggests insulin resistance precedes compensatory 
hyperinsulinemia. According to this model, overworking of β-cells leads to eventual 
exhaustion and failure (C J Nolan et al., 2006). However, an alternative hypothesis 
suggests hyperinsulinemia is the primary defect, which leads to downstream 
insulin resistance. This hypothesis is supported by several lines of evidence: 
rhesus monkeys become hyperinsulinemic before insulin resistance is evident 
(Hansen & Bodkin, 1990); high-fat fed rats become hyperinsulinemic before insulin 
resistance is evident (Bonen et al., 2015); and mice with genetically impaired 
insulin production are protected from high-fat diet effects compared to their wild-
type controls (Mehran et al., 2012), demonstrating a need for hyperinsulinemia in 
the progression to diabetes 
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Hyperinsulinemia as an initiating factor 
Over 40 years ago, Olefsky et al. demonstrated that hypertriglyceridemia 
and hyperinsulinemia precede insulin resistance in humans (Olefsky, Crapo, 
Ginsberg, & Reaven, 1975). In fact, genetic prevention of hyperinsulinemia in high-
fat diet fed mice prevents weight gain and insulin resistance (Mehran et al., 2012). 
Conversely, rats and humans administered exogenous insulin develop insulin 
resistance after forced hyperinsulinemia (Del Prato et al., 1994; Destefano, Stern, 
& Castonguay, 1991). 
Hyperinsulinemia is conceivably due to either increased entry into 
circulation or reduced clearance therefrom. Insulin production occurs specifically 
in the pancreatic β-cells and is tightly regulated in both production and storage. 
Not only does glucose stimulate secretion of existing insulin, but it also stimulates 
further production via transcription of preproinsulin mRNA which is translated as 
proinsulin, which is subsequently cleaved into two co-secreted peptides packaged 
in secretory granules: insulin and c-peptide (reviewed in Fu, Gilbert, & Liu, 2013). 
Insulin synthesis is perturbed by several stimuli; adipocyte signaling by leptin and 
FFA both reduce preproinsulin mRNA production (Bollheimer, Skelly, Chester, 
McGarry, & Rhodes, 1998; Pallett, Morton, Cawthorne, & Emilsson, 1997; Seufert 
et al., 1999), in spite of FFA’s acute stimulatory effects on insulin secretion. 
Increased β-cell mass could also contribute to increased insulin in circulation in 
the obese state. In both rodents and humans, β-cell mass increases in response 
to obesity (Butler et al., 2003; Dalbøge et al., 2013; Jetton et al., 2005; Mezza et 
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al., 2014; Steil et al., 2001) with a corresponding increase in insulin secretion 
(Polonsky, Given, Hirsch, et al., 1988; Polonsky, Given, & Van Cauter, 1988). 
Insulin clearance is primarily accomplished by hepatocytes, where 50-70% 
of insulin is cleared on the first pass through the portal vein (Duckworth & Kitabchi, 
1981). Hepatic insulin clearance is reduced in obesity and inversely correlates with 
hepatic lipid accumulation (Kotronen, Vehkavaara, Seppälä-Lindroos, Bergholm, 
& Yki-Järvinen, 2007; Kotronen, Westerbacka, Bergholm, Pietiläinen, & Yki-
Järvinen, 2007). Lipid perfusion alone is sufficient to significantly lower insulin 
clearance in rats (Svedberg, Strömblad, Wirth, Smith, & Björntorp, 1991) and dogs 
(Yoshii et al., 2006), suggesting a close link between excess lipid exposure and 
impaired hepatic insulin clearance. Conversely, obese human children and 
adolescents exhibited increased hepatic insulin clearance upon weight loss 
(Escobar et al., 1999).  
Insulin Secretion regulation and dysregulation by different nutrients 
 Insulin secretion is a tightly regulated process arising from a 
characteristically nutrient-sensing cell. Insulin secretion follows a general pattern 
in two phases: first phase insulin secretion exhibits a brief drop in insulin exocytosis 
from β-cells, followed by a rapid peak of insulin release on the scale of minutes; 
second phase insulin secretion follows with a gradual decline in insulin release on 
the scale of minutes to hours. Loss of first phase is one of the first hallmarks of 
early diabetes, and is generally coincident with an increased second phase insulin 
secretion (Perley & Kipnis, 1967). The two pathways have distinct but 
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complementary mechanisms. First phase insulin secretion is stimulated by the 
rapid conversion of glucose to ATP in the β-cells, which triggers ATP-sensitive 
potassium channels (KATP channels), whose closure depolarizes the cell 
membrane. Voltage dependent calcium channels (VDCCs) then open, permitting 
calcium entry to stimulate insulin granule exocytosis through SNARE-mediated 
exocytosis (reviewed in V Poitout & Robertson, 1996).  Second phase insulin 
secretion is dependent on initial triggering and can enhance it. However, regulation 
of second-phase insulin secretion remains a challenge to study, and so far several 
factors have been shown to regulate second-phase, including FFA (C J Nolan et 
al., 2006), lipid accumulation (Erion, Berdan, Burritt, Corkey, & Deeney, 2015), 
incretins such as GLP-1 (Drucker & Nauck, 2006) and GIP via raising cAMP levels 
, and ROS (Pi et al., 2007), among others. 
 FA, specifically, play an important role in insulin secretion. The presence of 
endogenous or exogenous FFA are necessary for GSIS, possibly via GPR40, a 
FFA receptor on the plasma membrane (El-Azzouny, Evans, Treutelaar, Kennedy, 
& Burant, 2014; Itoh et al., 2003; Latour et al., 2007). However, a chronic excess 
of exogenous FFA inhibits insulin secretion, an effect compounded by excess 
glucose in the condition of GLT (reviewed in Vincent Poitout et al., 2010). FFA act 
through several mechanisms to influence insulin secretion. Glucose metabolism 
produces malonyl-CoA via ACC, which inhibits CPT-1, the main rate-limiting step 
in mitochondrial β-oxidation. FA-CoA which is spared from oxidation can be 
incorporated into complex lipid molecules such as DAGs and phospholipids 
  6 
capable of stimulating insulin exocytosis, a key component of the LC-CoA 
hypothesis (M Prentki & Corkey, 1996; Roduit et al., 2004).  
FA esterification (Roduit et al., 2004) and lipolysis (Christopher J Nolan, 
Madiraju, Delghingaro-augusto, Peyot, & Prentki, 2006) are both activated by 
products of glucose metabolism; inhibition of these processes abrogates the FFA 
enhancement of glucose stimulated insulin secretion. Collectively, this futile cycle 
has been called Glycerolipid/Fatty Acid (GL/FA) cycling, and β-cells express the 
necessary enzymes for this process. FA esterification is initiated by the formation 
of lysophosphatidic acid condensed from long-chain CoA (LC-CoA) and G3P. This 
product is then esterified with another LC-CoA via acylglycerol-3-phosphate 
acyltransferase to form phosphatidic acid. TAG is formed by the final esterification 
of a final LC-CoA with phosphatidic acid via DAG acyltransferase. Conversely, in 
the process of lipolysis, TAG is broken down by ATGL to yield DAG, which is 
subsequently hydrolyzed by HSL to MAG. MAG can be hydrolyzed to its final 
remaining FFA and glycerol via MAG lipase (MGL) or α/β hydrolase domain-6 
(ABHD6). Because β-cells do not express glycerol kinase, they cannot recycle the 
resultant glycerol; it is therefore released from the cell (MacDonald & Marshall, 
2000). 
The consequences of GL/FA cycling include increased intracellular 
concentrations of the above intermediates. While TAG has not been shown to 
affect insulin secretion, DAGs can bind the exocytotic protein Munc13-1 to 
stimulate exocytosis, and heterozygous Munc13-1 knockout mice demonstrate 
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impaired insulin secretion in response to glucose (Kwan et al., 2006). Further 
evidence for the role of DAG interaction with Munc13-1 includes a mutant form of 
the protein incapable of binding DAG, which similarly impairs glucose stimulated 
insulin secretion (Kwan et al., 2006). The lipolytic product of DAG, MAG also 
stimulates insulin secretion in a ROS dependent manner (Zhao et al., 2014). 
Over 40 years ago, Olefsky and colleagues observed a stark increase 
(30%) in circulating triglyceride and insulin response to glucose after a hypercaloric 
diet in humans (Olefsky et al., 1975) preceding insulin resistance. Subsequent 
studies have shown increased low-density and decreased high-density 
lipoproteins (Opie & Walfish, 1963; Vijayaraghavan, 2010) possibly due to insulin 
not effectively inhibiting hepatic lipolysis (Jensen et al., 1989). The role of FFAs in 
insulin secretion, particularly palmitate, is a primary focus of this work, and forced 
fragmentation of mitochondria through loss of Mfn2 sensitized β-cells to FFA 
induced insulin secretion at nonstimulatory levels of glucose, suggesting an 
interplay between mitochondrial morphology and insulin secretion regulation.  
Within the pancreatic islets of Langerhans reside β-cells, among other cell 
types such as α-cells and δ-cells. β-cells are characteristically sensitive to their 
nutrient environment and express GLUT2, a high-Km  plasma membrane glucose 
transporter (reviewed in Thorens, 2015) and glucokinase, a high-Km glucose 
phosphorylating enzyme, which both enable β-cells to respond quickly to changes 
in circulating glucose concentrations. The pyruvate derived from glucose is almost 
exclusively metabolized in mitochondria, further demonstrating the tight link 
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between β-cell glucose metabolism and nutrient sensing (Schuit et al., 1997). In 
addition, β-cells respond to fatty acids which can elicit insulin secretion 
independently of elevated glucose, through receptors such as GPR40 (El-Azzouny 
et al., 2014; Christopher J Nolan et al., 2006). As a result of this sensitivity, β-cells 
are also prone to damage from excess nutrient conditions, particularly elevated 
glucose and FFA (Molina et al., 2009; Vincent Poitout et al., 2010; Wikstrom et al., 
2007), a condition exploited by researchers to mimic the obese state using 
glucolipotoxicity (GLT; Y. Zhou & Grill, 1994). 
Mitochondria are responsible for oxidative phosphorylation, beta oxidation, 
and nutrient signaling to the rest of the cell. To facilitate and regulate these 
functions, mitochondria fuse and fission during the process of mitochondrial 
dynamics (Molina et al., 2009; Stiles & Shirihai, 2012). Mitochondrial dynamics 
influences the quality control of mitochondria (Y. Chen & Dorn, 2013; Twig et al., 
2008) and overall network health as a result via the PINK/Parkin system (Y. Chen 
& Dorn, 2013; Narendra et al., 2010; Pickrell & Youle, 2015; Yun et al., 2014; 
Ziviani, Tao, & Whitworth, 2010). Mitochondrial fusion and fission are controlled by 
specific proteins: fusion requires Mfn1 and/or Mfn2 for fusion of the outer 
mitochondrial membrane, and OPA1 for fusion of  the inner mitochondrial 
membrane; fission utilizes Drp1, Fis1, and Mff (reviewed in Liesa & Shirihai, 2013). 
Together, these processes regulate mitochondrial morphology and function, both 
of which can be examined by long-utilized tools such as microscopy and 
respirometry.  
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Because mitochondrial dynamics determine mitochondrial morphology and 
quality control, measuring morphology is a snap shot of the process of 
mitochondrial dynamics. Our lab and others have previously published a link 
between mitochondrial morphology and nutrient availability suggesting a possible 
functional role for morphology as opposed to morphology being a passive outcome 
of dynamics (Anello et al., 2005; Twig et al., 2008; Wikstrom et al., 2007). This link 
is observed in cellular subpopulations of mitochondria, as brown adipose tissue 
(BAT) mitochondria near lipid droplets are more elongated and express more ATP 
synthase (Benador et al., 2018) and inhibition of mitochondrial fusion inhibits BAT 
thermogenesis (Mahdaviani et al., 2017). Similarly, mitochondrial morphology 
proteins such as Mfn2 exert effects beyond morphological regulation: a fusion-
deficient truncated form of Mfn2 is able to regulate metabolism in skeletal muscle 
(Pich et al., 2005). 
Regulation of mitochondrial dynamics and quality control 
Mitochondrial fusion is regulated by fusion proteins: mitofusins 1 and 2 
(Mfn1 and Mfn2) fuse the outer mitochondrial membrane, and Optic Atrophy 1 
(OPA1) fuses the inner mitochondrial membrane. Conversely, mitochondrial 
fission factor (Mff) and Dynamin Related Protein 1 (Drp1) are responsible for 
mitochondrial fission. These proteins tightly regulate mitochondrial dynamics and 
morphology via hydrolysis of GTP to power their activities (Sesaki & Jensen, 1999; 
Shaw & Nunnari, 2002; Yaffe, 1999). Critically, mitochondrial morphology and 
dynamics control mitochondrial degradation via autophagy or mitophagy (Dagda 
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et al., 2009; Twig et al., 2008), probably by influencing mitochondrial membrane 
potential and PINK1-mediated phosphorylation of Mfn2 (Y. Chen & Dorn, 2013; 
Pickrell & Youle, 2015; Song, Mihara, Chen, Scorrano, & Ii, 2015; Yun et al., 2014).  
PINK1, which is normally degraded in polarized mitochondria, is stabilized on 
depolarized mitochondria (Narendra et al., 2010) due to inhibition of its protease. 
Stabilized PINK1 phosphorylates Mfn2, which is targeted by Parkin. Parkin 
ubiquitinates Mfn2, whose ubiquitination designates mitochondria destined for 
removal by mitophagy. 
 The selective elimination of defective mitochondria, or mitophagy, is a 
critical housekeeping process within a cell; Parkin is named for the disease that 
results from defective parkin: Parkinson’s disease (Y. Chen & Dorn, 2013). Our lab 
has previously published the critical importance of mitochondrial quality control and 
network maintenance for maintaining cell health in the excess nutrient environment 
(Molina et al., 2009; Twig et al., 2008; Wikstrom et al., 2007). Mfn2 is also the 
target of ubiquitination by a second, redundant pro-mitophagy ubiquitin ligase, 
MUL1, whose loss exacerbates the Parkin-null phenotype (Yun et al., 2014). This 
is a tightly regulated process, where deubiquitinases such as ubiquitin carboxyl-
terminal hydrolase L1 (UCH-L1) act in opposition to the ubiquintation of Mfn2 and 
other proteins (Costes et al., 2011; Costes, Gurlo, Rivera, & Butler, 2014). 
Mitophagy is well-controlled but can fail at any of the above steps. While the above 
mechanisms describe the targeting of defective mitochondria to the mitophagic 
process, functional mitophagy also requires proper lysosomal function, which has 
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been shown to be impaired in excess nutrient conditions (Trudeau et al., 2016), a 
situation rectified by re-acidifying the lysosomes. 
 This concept of constant mitochondrial fusion, fission, degradation, and 
regulation has led to the concept of a mitochondrial lifecycle, such that 
mitochondria live and die by dynamics. 
Measurement of mitochondrial shape and function 
  Mitochondria are significantly smaller than the cells they reside in, with a 
diameter around 1 µm and a length from 1 µm to >10 µm as part of a frequently 
overlapping network. As a result, direct quantification of their function and shape 
poses a unique challenge. The most common approach to measure mitochondrial 
function is via cellular oxygen consumption because mitochondria consume a vast 
majority of the oxygen in a cell (Liesa & Shirihai, 2013). Oxygen consumption has 
been measured since the early days of cell biology (Chance & Williams, 1956) and 
still provides one of the most direct measures of mitochondrial function and health. 
Oxygen consumption measurement can be performed on pieces of tissue, 
spheroids of cells, monolayers of cells, perforated versions of the aforementioned 
samples (via detergents, etc.), and on isolated mitochondria. Each of these 
preparations provide slightly different information. For example, a monolayer of 
cells still must transport substrates and treatments across a plasma membrane, 
whereas perforated cells or isolated mitochondria bypass cellular substrate 
transport machinery.  
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 Measurements of oxygen consumption are usually performed in the 
presence of specific substrates providing electrons to Complex I and/or to Complex 
II, such as glucose or succinate, respectively. Such granular approaches provide 
a tool to tease apart the specific contributions of each fuel and/or complex to the 
oxygen consumption of the sample. Additional compounds provide tools to inhibit 
or activate specific complexes and transporters, such as oligomycin, which inhibits 
Complex V (ATP synthase), Etomoxir, which inhibits CPT-1, or FCCP, which 
strongly uncouples mitochondria. Uncoupled respiration is frequently used to 
measure the reserve capacity of mitochondria within a cell, e.g. the maximal 
respiration capacity. Uncoupled respiration (also known as proton leak) is named 
as such because coupled respiration is defined as oxygen consumption utilized for 
ATP synthesis (e.g. oxidative phosphorylation). The concept of proton leak is an 
important metric of the efficiency of mitochondria: how well they convert fuel to 
ATP. Measuring leak can provide valuable information on the integrity of the inner 
mitochondrial membrane or activity of distinct proteins such as the BAT-specific 
uncoupling protein 1 (UCP-1) (Wikstrom et al., 2014; Zingaretti et al., 2009). 
 Yet another approach to characterize mitochondria is metabolomics. 
Metabolomics is the fusion of historical methods such as radiolabeling or 
isotopomer labeling with new technology such as advanced chromatography and 
mass spectroscopy and high-throughput data handling (Sauer, 2006). Inspired by 
genomics and proteomics approaches, metabolomics collects vast information 
about isotopomer enrichment and uses modern computing power to model and 
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derive the meaning and biological basis of labeling patterns (Buescher et al., 
2015). By combining this approach with oxygen consumption and the fuel 
dependency measurements derived therefrom, metabolomics enables specific 
dissection of steady-state concentrations and flux through various metabolic 
pathways, including the TCA cycle (Buescher et al., 2015; Sauer, 2006; Young, 
2013) and fatty acid metabolism (Argus, Yu, Wang, Williams, & Bensinger, 2017). 
 Powerful computers have enabled the processing of data in new and 
previously impossible ways. Yet another advance provided by the march of 
technological progress is advanced light microscopy and image analysis. Light 
microscopy has advanced in recent years by discovery of novel ways to overcome 
the refraction limit set forth by physical laws inherent to the wavelength of incident 
light. Structured illumination microscopy (SIM) uses a Fourier transform of 
interference patterns from the sample; Stimulated emission depletion (STED) 
microscopy uses a donut-shaped laser beam to quench the airy disk of the 
fluorophore of interest and localize its point source; and stochastic localization 
microscopy such as the Zeiss Airyscan uses powerful computers to deconvolve 
the point spread function of a fluorophore (Weisshart, 2014). Modern computing 
power has greatly enhanced the resolution of light microscopy beyond the 
theoretical refraction limit  of ~250nm (Abbe, 1873) to ~120nm and even less in 
some cases. The resultant super-resolution images can be analyzed and 
quantified faster and more accurately than ever before as a result of modern 
computing power. Not only does each of the above techniques provide many 
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gigabytes to terabytes of data per experiment, but modern analysis programs such 
as ImageJ and its plugin-rich fork FIJI (Schindelin et al., 2012) enable rapid 
automated analysis of these large data sets, often times enabled by resource-
intensive machine learning algorithms for segmentation and quantification of 
image objects (Arganda-Carreras et al., 2017). Image analysis programs also 
contain tools for generating macros – sets of repetitive instructions to be repeated 
on every image for analysis. Macros enable rapid, repeatable, and unbiased 
analysis of large image data sets. 
Goals of the thesis 
 The mechanism of regulation of basal insulin secretion remains elusive and 
is a central focus of this work. Mitochondrial fragmentation and fatty acid 
metabolism present several potential druggable control points, promising novel 
treatments for obesity and diabetes, for instance modulating activity of CPT1, the 
rate-limiting step of mitochondrial β-oxidation. A broad, nontargeted approach 
investigating the metabolic consequences of knockdown of Mfn2 provides a basis 
from which future studies can be conducted in immortalized cell models in addition 
to examining mechanisms of the metabolic changes incurred in this model. 
Measurement of many mitochondrial parameters, particularly via microscopy, 
poses several unique challenges for repeatable, unbiased quantification. Providing 
the basis for this type of analysis is beneficial for the scientific community at large 
– easily accessible and customizable mitochondrial analysis tools are rare. 
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1) Aim 1 (Chapter Two) will determine the role of mitochondrial 
fragmentation in basal insulin secretion and examine mechanisms for 
the palmitate-induced increase in non-glucose-stimulated insulin 
secretion. 
2) Aim 2 (Chapter Three) will investigate the role of Mfn2 downregulation 
in an immortalized cell line utilizing high-throughput approaches to 
elucidate the metabolic effects of mitochondrial morphology on 
metabolic parameters, such as fuel preference and respirometry. 
3) Aim 3 (Chapter) Four will describe novel image segmentation methods 
and image analysis methods designed to increase repeatability and 
throughput of measurement of subcellular structures in high-resolution 
micrographs. 
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Figure 1.1. Conventional model for the progression of T2D development.  
Obesity is associated with Insulin resistance, which leads to compensatory 
hypersecretion of insulin through several mechanisms, including β-cell 
hypertrophy and exocytosis of insulin. This overworking of β-cells leads to cellular 
damage and loss of β-cell mass. The loss of insulin secretion capacity induces 
T2D and uncontrolled glycemia. 
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Figure 2.1. Alternative model for T2D progression with a focus on HI.  
Excess nutrient intake induces hypersecretion of insulin in obese subjects by 
several mechanisms, including increased exocytosis via FFA/GL cycling, The 
excess insulin induces insulin resistance in peripheral tissues contributing to a 
vicious cycle of hypersinulinemia and insulin resistance, eventually leading to β-
cell failure and loss of β-cell mass, followed by development of overt T2D. 
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ABSTRACT 
There are two competing hypotheses to explain the development of T2D: 
insulin resistance initiating hyperinsulinemia or the inverse thereof. The 
mechanisms governing basal insulin secretion are not known, but alterations 
therein are well known to be associated with obesity and diabetes. Pancreatic 
islets from obese type 2 diabetic (T2D) subjects are characterized by decreased 
glucose stimulated insulin secretion (GSIS) and increased basal nonstimulated 
secretion. In this study, we identify Mitofusin 2 (Mfn2) is reduced in obese high fat 
diet mice and zucker rats. β-cell specific Mfn2 deletion elevated nonstimulated 
insulin secretion, in addition to recapitulating other features of obese prediabetic 
β-cells, such as enhanced fatty acid oxidation and disturbed second-phase GSIS 
oscillations. Mfn2-deficient β-cells demonstrate increased fatty acid uptake and 
preferentially secrete insulin in response to fatty acids, specifically palmitate at 
nonstimulatory glucose concentrations. We have found that Mfn2 bridges obesity 
and diabetes by inducing hyperinsulinemia in response to increased fatty acid 
sensitivity in the pancreatic beta cell. 
 
INTRODUCTION 
 Hyperinsulinemia is generally thought to be a compensatory 
mechanism by the pancreatic β-cell in order to preserve glucose homeostasis in 
the face of insulin resistance. However, an alternative hypothesis stipulates that 
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hyperinsulinemia may be an initiating factor in the progression of glucose 
intolerance (Czech, 2017). Over 40 years ago, Olefsky et al. demonstrated that 
hypertriglyceridemia and hyperinsulinemia precede insulin resistance in humans 
(Olefsky et al., 1975). In fact, genetic prevention of hyperinsulinism via 
heterozygous ablation of the insulin gene in high-fat diet fed mice prevented weight 
gain and insulin resistance (Mehran et al., 2012). Conversely, rats and humans 
administered insulin via minipumps develop hyperinsulinemia followed by insulin 
resistance (Del Prato et al., 1994; Destefano et al., 1991). It remains a challenge 
to study this alternative hypothesis of T2D due to the limited understanding of the 
factors regulating basal insulin secretion. Unlike glucose-stimulated insulin 
secretion (GSIS), the mechanisms regulating basal insulin secretion are currently 
not known. To our knowledge, no study has attempted to determine the specific 
role of mitochondria and mitochondrial morphology in the changes of basal 
secretion that result from obesity, regardless of the central role of mitochondria in 
metabolism. The pancreatic β-cell mitochondria are integrators of diverse fuel 
signals, such as carbohydrate, protein, and fat, positioning them at the intersection 
of metabolism and nutrient regulation.  
Mitochondria are highly dynamic organelles whose morphology is regulated 
by continuous cycles of fusion and fission, collectively termed mitochondrial 
dynamics (Frank, 2006; Skulachev, 2001). Mediators of mitochondrial fusion 
include Optic Atrophy 1 (OPA1) and mitofusins 1 (Mfn1) and 2 (Mfn2); fission is 
mediated by dynamin related protein 1 (Drp1), mitochondrial fission protein 1 
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(Fis1), and mitochondrial fission factor (Mff).  Mitochondrial networking contributes 
to mitochondrial quality control mechanisms, allowing for the buffering of 
mitochondrial reactive oxygen species (ROS) and calcium overload (Frieden et al., 
2004; Szabadkai et al., 2004), as well as the selective removal of dysfunctional 
mitochondrial units by mitophagy (Twig et al., 2008).   
Mfn2 expression is decreased in different tissues by diet induced obesity 
and contributes to tissue dysfunction (Bach et al., 2003; Le Blanc et al., 2012; Pich 
et al., 2005; Sorianello et al., 2012). Changes in mitochondrial morphology have 
been reported in the β-cells isolated from Type 2 Diabetic patients, Zucker Diabetic 
Fatty rats, and in diet induced obesity (Anello et al., 2005; Bindokas et al., 2003; 
Fex et al., 2007; Higa et al., 1999).  Previously, we found that fragmentation due 
to extended exposure to high levels of nutrients stems from nutrient-induced 
inhibition of mitochondrial fusion, rather than an increase in mitochondrial fission 
(Molina et al., 2009). In order to investigate the time-dependence of these 
phenomena, we utilized Zucker fatty rats and Zucker diabetic fatty rats at 12 weeks 
of age, prior to the onset of overt diabetes in the Zucker diabetic fatty rats around 
14 weeks of age. These experiments revealed that fragmentation of mitochondria 
preceded overt diabetes. Furthermore, Cerqueira et al. reported that calorie 
restricted animals, which have increased life spans and lower incidence of 
diabetes, displayed an increase in Mfn2 expression in both adipose tissue and 
skeletal muscle. Additionally, serum from calorie restricted animals increased Mfn2 
expression in INS-1 cells (Cerqueira et al., 2016; Cerqueira, Cunha, Laurindo, & 
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Kowaltowski, 2012). However, whether Mfn2 plays an important role in β-cell 
nutrient sensing and secretory function is unknown. As a result, we investigated 
the consequences of manipulation of mitochondrial morphology via modulation of 
Mfn2 expression in primary tissue.  
Mfn2 has been implicated in the regulation of mitochondrial function in 
addition to its role in mitochondrial fusion. Knockdown of Mfn2 results in altered 
mitochondrial bioenergetic function, as reduced glucose oxidation and decreased 
oxygen consumption in primary rodent muscle and muscle-derived cell lines is 
evident (Bach et al., 2003). Additionally, reduced substrate oxidation and 
mitochondrial membrane potential has also been observed in the same cell types, 
and overexpression of a truncated Mfn2 lacking fusion activity showed opposing 
effects (Pich et al., 2005). We and others recently demonstrated that removal of 
Mfn2 altered substrate preference and impaired thermogenesis in brown adipose 
tissue (BAT) (Boutant et al., 2017; Mahdaviani et al., 2017). These results 
collectively show that mitochondrial morphology and tissue function are intimately 
connected.  
Part of the aforementioned intimate connection is fuel preference for the 
mitochondria, cell, and insulin secretion. Acute exposure to free fatty acids (FFA) 
acutely increases insulin secretion, particularly through monoacylglycerol and 
other species (Pi et al., 2007); conversely, chronic exposure to elevated FFA 
inhibits mitochondrial quality control and insulin secretion in β-cells (Erion et al., 
2015; Molina et al., 2009; Twig et al., 2008; Wikstrom et al., 2007). Suggesting a 
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necessary balance in fatty acid content, other data shows either HSL activity or 
exogenous FFA are necessary for robust insulin responses to glucose. 
Hyperlipidemia resulting from short term caloric excess has been shown to 
increase insulin in vivo in the absence of hyperglycemia (Olefsky et al., 1975). To 
address the role of nutrient-induced inhibition of mitochondrial fusion in the 
development of β-cell dysfunction and diabetes, we investigated mitochondrial 
fusion proteins in vivo, ex vivo, and in vitro.  Given our published data showing that 
Mfn2 expression in β-cells in vitro is reduced by high fat exposure (Molina et al., 
2009) and that fragmentation and Mfn2 inhibition promote fatty acid oxidation 
(Mahdaviani et al., 2017), we hypothesized that Mfn2 downregulation in obesity 
could be responsible for lipid-induced insulin secretion at nonstimulating glucose 
levels characteristic of β-cells from obese subjects (C J Nolan et al., 2006). These 
findings contribute to the understanding of diabetes by demonstrating a secretion-
inducing fuel-preference switch in the pancreatic β-cell which increases basal 
insulin secretion in response to free fatty acids, presenting a potential target for 
regulation of basal insulin secretion. 
 
EXPERIMENTAL PROCEDURES 
Generation and genotyping of βMfn2KO mice 
The generation of Mfn2loxP mice has been previously described by Hsiuchen 
Chen (H. Chen, McCaffery, & Chan, 2007).  Briefly, ES clones (129 strain) carrying 
targeted mutations were injected into C57BL/6 blastocysts. Founder chimeric mice 
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were bred to Black Swiss mice, and agouti offspring were bred to FLPeR mice to 
remove the neomycin resistance cassette. Resulting mice were maintained as 
homozygous stocks (Farley et al., 2000).  B6.Cg-Tg(Ins2-cre)25Mgn/J mice (RIP-
Cre) were obtained from JAX mice (Bar Harbor, ME) and bred with homozygous 
Mfn2loxP to generate F1, double heterozygous mice.  F1 mice were then bred with 
the original Mfn2loxP mice in order to generate the βMfn2KO mice.  Littermates 
include Mfn2loxP +/+  RIP-Cre -/- and Mfn2 +/- RIP-Cre -/- which were used as WT 
controls.  In addition, Mfn2loxP +/- RIP-Cre +/- were tested and found to possess a 
mild phenotype.   
Genotyping was performed by PCR of tail snip lysates (Viagen, DirectPCR, 
Los Angeles, CA) obtained during the weaning of pups.  Floxed Mfn2 transgene 
was detected using GoTaq Green Master Mix (Promega, Madison, WI) and the 
following primers: gaa gta ggc agt ctc cat cg and ccc aag aag agc atg tgt gc.  The 
unexcised conditional band is 810bp and the WT is 710 bp.  Cre transgene was 
detected in the same samples by following the genotyping protocol provided by 
JAX Mice using the following primers: gcg gtc tgg cag taa aaa cta tc and gtg aaa 
cag cat tgc tgt cac tt. 
Confocal Microscopy 
Confocal microscopy was performed on live cells in glass bottom dishes 
(MatTek, Ashland, MA) using an inverted Leica TCS SP2 confocal microscope or 
Zeiss LSM 710 DUO with a plan-apochromat 100x (NA = 1.4) oil immersion 
objective.  Mitochondria were stained with 3.5nM TMRE (Invitrogen Molecular 
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Probes, Eugene, OR.) for 45 minutes prior to imaging.  Insulin promoter mediated 
paGFP expression in the mitochondrial matrix was induced by lentiviral 
transduction.  The generation and use of these constructs was previously 
described in detail (Molina et al., 2009).  
Pa-GFP activation and imaging of mitochondria 
Photoconversion of PA-GFPmt to its active (fluorescent) form was achieved 
by using 2-photon laser (750nm) to give a 375 nm photon-equivalence at the focal 
plane. This allowed for selective activation of regions that have submicron 
thickness and are less than 0.5 μm2. Using the multi-track scanning mode of the 
Zeiss LSM-710 microscope, red-emitting TMRE was excited with a 1 mW 543 nm 
helium / neon laser set at 0.3% and emission was recorded through a BP 650–
710nm filter. Activated PA-GFPmt protein was excited using a 25 mW 488 nm 
argon laser set at 0.2%. Emission was recorded through a BP 500–550 nm filter. 
Prior work from our lab has determined optimal concentrations of probes and laser 
power to avoid photobleaching in our models (Twig et al., 2008), which was utilized 
in this study to avoid similar artifacts.  
Batch Insulin Secretion 
Islets were cultured in RPMI 1640 media supplemented with 10% FBS and 
50 U/ml penicillin and 50 μg/ml streptomycin overnight prior to insulin secretion 
assays.   Insulin secretion was run in 5 technical replicates and collected in a 
parallel fashion.  Islets were washed and preincubated at 2mM glucose for 30 min 
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in modified Krebs-Ringer bicarbonate buffer (KRB). This was followed by a 30 min 
incubation in media containing either 3 mM or 15 mM glucose. Media was collected 
and stored at –20°C for insulin measurement. Insulin was measured by 
radioimmunoassay (LINCO Research Inc., St. Charles, MO).  Normalization was 
performed by lysing the cells and measuring total insulin content.  In order to 
measure insulin content, islets from three different animals were measured per 
genotype.  For each animal, islet insulin content was measured in triplicate.  For 
each measurement, six islets were lysed and diluted for insulin and protein 
measurements.  Insulin was measured using the HTRF Insulin Assay (Cisbio 
Bioassays).  Total protein was measured using the Bio-Rad Protein Assay, which 
is based on the Bradford method.  Insulin content is presented as nanograms of 
insulin per milligram of total protein. 
Islet Perifusion 
Islets were perifused in a column as described (Cunningham, Deeney, 
Bliss, Corkey, & Tornheim, 1996).   A collection of 50 islets was laid between 2 
layers of Cytodex microcarrier beads (Sigma). The column used was 0.4 cm in 
diameter and 4 cm high and contained in a temperature controlled environment at 
37 °C. Perifusion reagents were pumped through the column at 0.3 ml/minute 
using an analog tubing pump (Ismatech REGLO pump, type ISM 827, model 
78,016–30; Cole-Parmer Instrument Co., Chicago, IL). Islets were perifused with 
Krebs-Ringer Bicarbonate buffer with added 0.5 % BSA for 30 minutes to allow for 
equilibrium. Eluted samples were collected at 30 second intervals for 48 minutes. 
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Basal levels of insulin were determined with 3mM glucose perifusion for 6 minutes, 
response to 15mM glucose was measured for 32 minutes and 15mM glucose; KCl 
was perifused for 10 minutes.  
Western Blot 
Primary antibodies used include anti-Mfn2 (#56889, AbCam, Cambridge, 
MA), anti-Beta-Actin (#AB8227, AbCam, Cambridge, MA), and anti-porin 
(#AB15895, AbCam, Cambridge, MA). 
qPCR  
Total RNA was isolated from islets using the Qiagen RNesay Plus Mini Kit.  
cDNA was obtained from RNA by a reverse transcriptase reaction using Applied 
Biosystems High Capacity cDNA Reverse Transcription Kit.  Changes in gene 
expression were detected with SYBR Green.  All samples were normalized to 18S 
content, which served as an endogenous control.   
Respirometry 
Respirometry of whole murine islets was performed using the Seahorse 
Bioscience XF 24 platform (Agilent Technologies, Santa Clara, CA) as previously 
described (Ferrick, Neilson, & Beeson, 2008).  βMfn2KO and wild type islets were 
isolated and allowed to recover after isolation in culture overnight before 
respirometry was performed. Islets were placed in a 24 well islet plate and the 
addition of an 80 micron screen kept islets in place directly under the oxygen 
sensors. Data was normalized by islet number. Drug concentrations were as 
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follows: oligomycin (5μM), FCCP (1μM), rotenone (5μM) and antimycin A (5μM) 
(Sigma). INS1 cells were transfected with a micro-RNA mfn2 KD delivered by 
adenovirus at a MOI of 500. After 3 days, mitochondria were isolated and 
respirometry was performed using the Seahorse XF 24 platform. In order to ensure 
the amount of mitochondria was consistent between groups; 40 μg of protein was 
loaded into every well. 
Glucose Tolerance Test (GTT) 
Mice were fasted (supplied with water ad libidum) for 12 hours overnight 
prior to the GTT.  The volume (µL) of 10% glucose to be injected per mouse is 
determined by multiplying mouse weight (in grams) by 5, or 0.5mg/g body weight.  
Initial time zero blood glucose measurements were taken using a glucometer with 
a drop of blood obtained from the tail.  After blood glucose for time zero is taken, 
the mice were given an intraperitoneal (IP) glucose injection and blood glucose 
measurements were taken at 15, 30, 60, 90, and 120 minutes.  Lab chow was 
reinstated to cages once the last glucose measurement and blood sample was 
taken.   
Fluorescent measurement of mitochondrial H2O2 production and Generation of ex-
vivo knockout 
A mitochondrially targeted fusion protein (Orp1-roGFP) of cytosolic ORP1 
and redox-sensitive GFP (roGFP) (Morgan, Sobotta, & Dick, 2011) was 
transduced into dispersed Mfn2 fl/fl mouse islet cells using an adenoviral vector at 
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a MOI of 200 particles per cell. This virus was co-transduced with 200 MOI 
adenoviral Cre containing DsRed as a reporter of transduction. The MOI of each 
virus was determined to have over 90% transduction efficiency via titration and 
measurement of reporter fluorescence. The cells were then reaggregated in the 
presence of both viruses into a pseudo-islet (5,000 cells per reaggregated islet) by 
centrifugation at 1,643 g in a 96-well V-bottom plate and cultured overnight. Media 
was changed the following morning and the islets were cultured for 3 days in RPMI 
(11mM glucose; 10%FBS; 1% penicillin/streptomycin) before being transferred to 
glass-bottom confocal dishes in 3 mM glucose basal Krebs buffer (Table 1.2).  
Islets were imaged after a 30-minute preincubation in basal buffer and then 
the glucose concentration was increased to 15 mM before imaging 20 minutes 
after this addition. For normalization, the fully reduced state was achieved by 
addition of 5 mM DTT for 15 minutes; the fully oxidized state was achieved by 
addition of 0.5 mM H2O2 for 10 minutes. For imaging experiments, 10mL of buffer 
was diluted after addition of appropriate glucose, 0.5mL of 200mM CaCl2, and 
0.25g of fatty acid free BSA (0.5% final). Volume was adjusted to 50mL after 
adjusting pH to 7.4. 
The imaging plate (#627870, Greiner bio-one) containing 8 to 10 islets per 
condition (1 per quadrant) was imaged on an Olympus IX 70, equipped with an 
Andor Zyla VSC-03062 camera, incubation, and CO2 environmental control. 
Wavelengths are expressed as wavelength (bandwidth). Images were acquired 
with 395(15)nm oxidized and 470(40)nm reduced excitation (ex) and 525(50)nm 
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emission (em) for both excitations. The exposure time each ex/em pair was 
determined at basal glucose during preincubation, and the baseline FI of both 
oxidized and reduced was set as close to equal as possible; e.g. the ratio of 
oxidized/reduced fluorescence was set to 1 at the outset of each experiment. 
Compound additions (glucose, DTT, and/or H2O2) were performed as 
additions of 100X concentrated solutions added to the well for imaging. After 
addition of the compounds, the volume (500μL initial, increasing with each 
sequential addition) of each quadrant was gently yet thoroughly mixed a minimum 
of 15 times with a 1000μL pipet, after which the islets were incubated for the times 
indicated. 
Metamorph image analysis software (Molecular Devices) was used to 
quantify whole islet average fluorescence in each channel after cropping and 
thresholding each image in the green channel (which had a larger signal/noise 
ratio) to remove background. The baseline ratio (oxidized/reduced FI) was set to 
1 and other values expressed as fold-change for calculation and comparison 
between independent experiments. We then performed a Wilcoxon 
(nonparametric, paired) test for significance in which islets from each mouse were 
aggregated and each experiment was treated as an n value.  
Representative image generation 
Representative images were generated using FIJI (https://fiji.sc/). Images 
were cropped for detail, separated into respective channels, and the window and 
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level parameters were adjusted identically per channel in all images to emphasize 
the fluorescent structures in the images without manipulation of raw pixel values.  
C12-BODIPY uptake  
INS-1 cells transduced with adenoviral shRNA (Welgen, MA) overnight 
were cultured for 3 days to knockdown Mfn2. Mfn2-KD INS1 cells were incubated 
for 45 min with 200nM C12-BODIPY 558/568 in 11mM glucose RPMI (0.1% FBS), 
after which the media containing BODIPY-labeled FAs was removed, fresh, 
phenol-red-free DMEM media (1% FBS) was placed on the cells, and the cells 
were imaged in an Operetta high-content imager at 37°C with 5% CO2 to evaluate 
BODIPY fluorescence inside the cells. These images were then quantified using 
the Operetta Harmony software for average cytosolic fluorescence after 
thresholding and removing background. 
 
RESULTS 
Mfn2 was reduced under HFD and in the ZDF rat 
 Previously, we published that reduced fusion activity fragments 
mitochondria upon exposure to excess palmitate (Molina et al., 2009). In order to 
investigate this effect in vivo, we examined the levels of the mitochondrial fusion 
protein Mfn2 in high fat diet fed mice, a model of diet induced obesity and diabetes. 
C57Bl6 mice were placed on a high fat diet (HFD, 58% kcal from fat: hydrogenated 
coconut oil, #D12331, Research Diets, New Brunswick, NJ) for 12 weeks vs. a 
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control diet with 11% kcal from fat (#D12329, Research Diets, New Brunswick, 
NJ). Glucose tolerance tests were performed weekly from weeks 8-12 to verify diet 
induced changes in glucose homeostasis.  Impaired glucose tolerance became 
evident at week 12 (Supp. Fig. 1.2). Mfn2 protein expression levels after 12 weeks 
were reduced by 67 % compared with control mice while mitochondrial mass (by 
porin) was unchanged (Fig. 1.2A).  
HFD feeding in mice induces both hyperglycemia and hyperlipidemia. To 
test if either or both of these two phenomena are required for reduction of Mfn2 
expression in islets, we examined islets isolated from Zucker rats. Three animals 
from each experimental group (Zucker Lean, Zucker Fatty, Zucker Diabetic Lean, 
and Zucker Diabetic Fatty) were assayed at eight weeks of age.  Comparison of 
the Zucker Fatty (Fig. 1.2B) and the Zucker Diabetic Fatty (Fig. 1.2C) to their 
corresponding lean control showed that Mfn2 was reduced in the Zucker Diabetic 
(by 41%), but not in the Zucker Fatty. These results suggest that the reduction of 
Mfn2 is inherently related to the increase in circulating triglyceride and 
compounded by hyperglycemia in the progression to overt diabetes. 
Deletion of Mfn2 in β-cells induced mitochondrial fragmentation  
To investigate the role of Mfn2 reduction in β-cell mitochondrial morphology, 
we created a mouse lacking Mfn2 in insulin secreting cells by using the Cre/LoxP 
system.  Rat Insulin Promoter (RIP)-mediated Cre expression produced excision 
of Mfn2 (β-Mfn2KO) in β-cells. Tissue specific excision of Mfn2 from isolated 
pancreatic β-cells was confirmed by PCR (Supp. Fig. 2.2A) and western blot 
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(Supp. Fig. 2.2B). Comparison of Mfn2 expression in other tissues (liver, muscle, 
heart, fat, thymus, and brain) obtained from β-Mfn2KO indicated that these tissues 
are not significantly affected (Supp. Fig. 2.2C).  
As Mfn2 deletion has been shown to change mitochondrial morphology to 
a fragmented state in different tissues, we determined whether this was the case 
in β-cells as well.  In order to distinguish β-cells during this imaging, dispersed islet 
cells were transduced with adenovirus encoding for mitochondrial photo-
activatable GFP (paGFP) driven by the Ins1 promoter, which is only active in β-
cells. TMRE was used to stain mitochondria in all cells. After photoactivating 
different cells, we identified the β-cells within dispersed islets and found that β-
cells from β-Mfn2KO mice show mitochondrial fragmentation (Fig. 2.2A). Indeed, 
cells in which photoactivation of GFP was not successful showed elongated 
mitochondria, supporting β-cell specific Mfn2 deletion and fragmentation (Fig. 
2.2B).  Since RIP-driven Cre has been shown to lead to expression in POMC 
neurons, all experiments were performed on islets isolated from body-mass 
matched WT and β-Mfn2KO mice (Fig. 3.2A) or from isolated islets from Mfn2 
floxed mice transduced with adenoviral Cre ex vivo, eliminating potential 
complications from hypothalamic Cre expression.  
β-Mfn2KO islets have increased insulin secretion at substimulatory glucose levels 
To test the effects of Mfn2 deletion on β-cell function, GSIS was measured 
in islets isolated from wild type and β-Mfn2KO mice. Loss of Mfn2 expression 
induced an impairment of glucose tolerance by 50 days of age (Fig 3.2B). Mfn2 
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deletion induced a 2 fold increase in insulin secretion at basal (3mM) glucose when 
compared to WT islets (Fig. 3.2C). Excision of Mfn2 ex vivo initiated a similar 
increase in basal insulin secretion, demonstrating that acute excision is sufficient 
to produce basal hypersecretion (Fig 3.2D). On the other hand, insulin secretion 
after glucose stimulation was not different between WT and β-Mfn2KO islets. While 
islets were size matched, we also measured insulin content to verify that the size 
matching was done properly as well as to test whether Mfn2 deletion could alter 
steady state levels of insulin in islets. We did not detect a significant change in 
insulin content between size matched WT and β-Mfn2KO islets (Fig. 3.2E).  
Mfn2 deletion in β-cells recapitulated the insulin secretion dynamics of obese islets 
In order to better understand the changes induced by Mfn2 deletion in β-
cell secretory function, we conducted islet perifusion experiments to quantify first- 
and second- phase insulin secretion (Fig. 3.2F).  β-Mfn2KO islets perifused with 
3mM glucose showed elevated insulin secretion when compared to WT islets, 
similar to the batch secretion experiments.  Upon increasing the glucose 
concentration to 15mM, control islets exhibit a short decline in insulin secretion, 
followed by a large 5-fold increase in secretion, as expected with phase I insulin 
secretion. Phase I is followed by a rapid decrease in secretion, which is followed 
by a gradual increase in secretion, consistent with the classic Phase II of insulin 
secretion, as shown in wild type mouse islets. On the other hand, β-Mfn2KO islets 
exhibit no pre-phase I decrease and no peak during phase I. The absence of phase 
I secretion was instead replaced by elevated insulin secretion for the duration of 
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exposure to high glucose during phase II in β-Mfn2KO islets. Subsequent exposure 
to 40mM KCl caused a similar increase in insulin secretion between both groups, 
although the β-Mfn2KO islets continued to secrete at a higher rate overall. In order 
to visualize the oscillatory nature of phase II insulin secretion, the perfusion data 
was processed with the OOPSEG smoothing program (Bradley, Steil, & Bergman, 
1995) and displayed in Fig. 3.2G. The β-Mfn2KO islets demonstrate disrupted 
oscillatory behavior in addition to impaired phase I and increased phase II 
secretion, phenomena also observed in human models of prediabetes.   
Deletion of Mfn2 increased mitochondrial ATP-synthesizing respiration under 
basal glucose  
Because insulin secretion and oxygen consumption are intimately related in 
the β-cell, we sought to determine if β-Mfn2KO islets demonstrate altered oxygen 
consumption in response to glucose or fatty acids using the Seahorse XF24 
respirometer. β-Mfn2KO islets exhibit increased basal oxygen consumption, 
demonstrating an increased energy demand (Fig. 4.2A). Islets typically display an 
increase in oxygen consumption with an acute increase in glucose concentrations 
(from 3mM to 20mM); however, this response is significantly lower in β-Mfn2KO 
islets because they exhibited a two-fold increase in respiration under low, basal, 
glucose, when compared to WT islets (Fig. 4.2B). This increase in respiration was 
indeed mostly attributed to an increase in ATP synthesis capacity, as it was 
oligomycin sensitive (Fig. 4.2C). Therefore, these data show that increased basal 
oxygen consumption in β-Mfn2KO islets is through an increase in the capacity of 
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mitochondria to produce ATP, resembling β-Mfn2KO mitochondria from brown 
adipose tissue. A dramatically increased oxygen consumption was observed in 
Mfn2-KD INS-1 cells compared with scramble control INS-1 cells, suggesting that 
Mfn2 knockdown elicits an increase in fatty acid uptake (Fig 5.2E) and oxidation 
(Fig 4.2D). 
Mfn2-deletion in β-cells sensitized insulin secretion to fatty acids 
Increased basal insulin secretion is a hallmark of islets from obese and 
diabetic animal models. To determine the mechanism of increased insulin 
secretion at basal glucose concentrations, we first investigated cytosolic calcium 
in islets lacking Mfn2, given calcium’s established role in GSIS. We observed no 
difference in cytosolic calcium levels between WT and β-Mfn2KO β-cells at basal 
(Fig. 5.2E) glucose conditions. Mfn2 inhibition has been shown to increase H2O2 
levels in other cell types and H2O2 is a molecule known to enhance insulin 
secretion(Heart, Palo, Womack, Smith, & Gray, 2012; Pi et al., 2007). Therefore, 
we investigated mitochondrial matrix H2O2 production utilizing a reversible redox 
sensor Orp1-roGFP. However, no differences in mitochondrial H2O2 levels were 
detected between WT and β-Mfn2-KO islets. Indeed, only exogenous H2O2 was 
sufficient to significantly increase oxidation of the probe localized to the 
mitochondrial matrix (Figs. 5.2C and 5.2D). 
Previous studies have shown that obesity or fat accumulation in β-cells is 
sufficient to induce fatty acid-mediated insulin secretion at basal glucose 
concentrations accompanied by an increase in fatty acid utilization (C J Nolan et 
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al., 2006). In order to investigate whether Mfn2 reduction could be responsible for 
sensitizing basal insulin secretion to fatty acids, palmitate-induced insulin secretion 
was markedly increased by 0.4mM palmitate in β-Mfn2KO islets (Fig. 5.2A), 
suggesting that Mfn2 downregulation in β-cells is sufficient to induce elevated 
insulin secretion in response to fatty acids at basal glucose concentrations. To 
determine if this increased sensitivity to fatty acids is accompanied by increased 
fatty acid utilization in cells lacking Mfn2, we transduced INS-1 832/13 cells with 
Mfn2 shRNA via an AAV vector (Mfn2-KD). We observed a significant increase in 
labeled 12-carbon FA uptake in the Mfn2-KD cells compared to their scramble-
RNA transduced controls (Fig. 5.2B), suggesting an increase in FA uptake and 
utilization with Mfn2-KD. 
 
DISCUSSION 
 Increased basal insulin secretion, loss of phase II oscillations, and 
increased insulin secretion in response to fatty acids are thought to contribute to 
the development of insulin resistance, but the relationship between mitochondrial 
morphology and these phenomena is unknown. Hyperinsulinemia has been the 
focus of historical and  recent research, as studies show that it might be a trigger 
for insulin resistance and T2D (Reviewed in Czech 2017). Our results indicate that 
mitochondria play an important role in the observed increased insulin secretion 
through the reduction of Mfn2 and concomitant increase of fatty-acid induced 
insulin secretion.  
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Consequences of arrest of mitochondrial fusion 
We and other labs have observed mitochondrial fragmentation in response 
to an excess nutrient environment. To address the mechanism, we examined 
Mfn2, which previous studies have shown is reduced in models of obesity and 
excess nutrients in muscle and adipose tissue (Bach et al., 2003; Le Blanc et al., 
2012; Pich et al., 2005; Sorianello et al., 2012). Here, we report a decrease in Mfn2 
expression in the β-cell in a rat model of obesity. Deletion of Mfn2 in the β-cell 
resulted in fragmented mitochondria in the absence of an excess nutrient 
environment. Mfn2 deletion was sufficient to recapitulate an obese-like phenotype 
in rodent β-cells, including altered responsiveness to fatty acids, which is 
characteristic of islets from obese/T2D subjects. One of the most compelling 
outcomes of deletion of Mfn2 is the capacity of free fatty acids (FFA) to promote 
insulin secretion under low glucose. This mimics previous findings from the Prenkti 
group showing islets from obese rats are more sensitive to fatty-acid induced 
insulin secretion at basal glucose (C J Nolan et al., 2006). The potentiation of 
insulin secretion in response to fatty acids may be of particular importance in states 
of insulin resistance or diabetes because these patients often have increased 
circulating triglyceride (Seigneur et al., 1994).  
Deleting Mfn2 in brown adipose tissue (BAT) mitochondria increases their 
capacity for ATP-generating fat oxidation (Mahdaviani et al., 2017). In this regard, 
we showed that deletion of Mfn2 in β-cells increased respiratory capacity linked to 
ATP synthesis under low glucose. The preferred nutrient of β-cells to oxidize in low 
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levels of low glucose is fatty acids. Thus, our data demonstrate that inhibiting Mfn2 
provides an extra capacity to take up and utilize fat for ATP synthesis in β-cells 
under low glucose. 
Fatty acids regulate insulin secretion 
Long-term exposure to saturated long-chain fatty acids, such as palmitate, 
has been shown to increase basal insulin secretion and blunt GSIS; however, 
acute exposure to saturated FFAs potentiates GSIS (Branstrom, Corkey, 
Berggren, & Larsson, 1997; El-Azzouny et al., 2014; Y.-P. Zhou & Grill, 1995; Y. 
Zhou & Grill, 1994). Exposure to palmitate has been shown to induce mild 
mitochondrial uncoupling (Carlsson, Håkan Borg, & Welsh, 1999). The data 
included herein suggest that Mfn2 downregulation may be involved in this switch 
in response from short term to long term exposure in β-cells by controlling the dose 
response of insulin secretion to palmitate, independently of ROS or Ca2+ 
alterations. This would fit with our data demonstrating a decrease in islet Mfn2 
expression in HFD fed mice and ZDF rats. Specific mechanisms regulating Mfn2 
expression have been described; decreased Mfn2 protein levels could be a result 
of phosphorylation and proteasomal degradation of Mfn2 (Chan et al., 2011; Ziviani 
et al., 2010), which has been shown in sarcoma U2OS cells in response to 
doxorubicin, an inducer of mitochondrial oxidative stress (Leboucher et al., 2012). 
Previous studies have shown an increase in glycerolipid/free fatty acid (GL/FFA) 
cycling in response to HFD in rats (C J Nolan et al., 2006; Christopher J. Nolan & 
Prentki, 2008; Christopher J Nolan et al., 2006). It is thought that this cycle alters 
  40 
insulin secretion through signaling intermediates, such as monoacylglycerols 
(MAGs), which activate exocytotic machinery via Munc13 (Marc Prentki, 
Matschinsky, & Madiraju, 2013). Given that Mfn2 deletion results in similar effects, 
it is conceivable that GL/FFA cycling could increase sensitivity to exogenous fatty 
acids in our system, particularly given their increased utilization by β-cells. Other 
studies have shown an important role for the cell membrane fatty acid receptor 
GPR40 in the augmentation of insulin secretion by FFA (El-Azzouny et al., 2014). 
These two potential mechanisms are not mutually exclusive; increased cycling 
could also contribute to increased release of FFA from the cell, which GPR40 
responds to by enhancing insulin secretion.  
Limitations and future directions 
Growing evidence indicates that alterations in β-cell mitochondrial function, 
including mitochondrial dynamics, contribute to the observed changes 
characteristic of β-cells in the development of T2D.  This includes the changes in 
mitochondrial architecture, insulin secretion at basal glucose, and loss of phase I 
secretion and phase II oscillations. In this study, we evaluated the effect of in vivo 
and ex vivo knockout of Mfn2. Due to considerations regarding the RIP-Cre system 
utilized for in vivo work, we subsequently excised Mfn2 exogenously, which 
removes potential confounding variables from expression of Cre recombinase in 
specific neurons of the hypothalamus (Schrepfer & Scorrano, 2016). This 
approach isolates the pancreatic islet from any effects due to overeating driven by 
Cre expression in the hypothalamus and further elucidates the mechanism 
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involved in the observed hyperinsulinemia. While we clearly show increased 
oxidation of palmitate by measuring oxygen consumption, this does not prove all 
fatty acids are equally utilized by β-cells or even determine multiple species of lipid 
that exert the insulin secretion augmentation. Further study should focus on 
describing differential effects of various fatty acids and may point to dietary 
changes for individuals plagued by hyperinsulinemia. Indeed, other work has 
shown that mono-oleoylglycerol is also capable of stimulating insulin secretion, 
pointing to the diverse nature of these stimuli (Saadeh et al., 2012). Our data 
demonstrate that changes in mitochondrial network architecture may underlie the 
changes in patterns of insulin secretion. As such, these data suggest that 
restoration of mitochondrial architecture may serve as a potential approach to 
restore normal insulin secretion. We show that Mfn2, a mediator of mitochondrial 
fusion and organelle tethering plays an important role in mediating coordinated β-
cell insulin secretion in response to glucose and fatty acid stimulation. This work 
provides evidence that nutrient induced alterations to β-cell mitochondrial 
dynamics can affect mitochondrial bioenergetic efficiency, capacity, and insulin 
secretion and thereby could contribute to the development of diabetes through an 
overt change in fuel utilization in the excess nutrient environment.  
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Figure 1.2. Mfn2 protein levels are decreased in pancreatic islets in models 
of obesity. 
(A) Male C57Bl6 mice were provided with a high fat or a control diet for 12 weeks.  
Western blot analysis of protein lysates obtained from islets isolated from HFD 
mice reveal a decrease in Mfn2.  Β-Actin and Porin expression was equal in both 
sets of mouse islets tested (n=3 mice per condition) Student’s T-Test, *p≤0.05. 
(B,C) Islets were isolated from 8 week old Zucker Lean (ZL), Zucker Fatty (ZF), 
Zucker Diabetic Lean (ZDL), and Zucker Diabetic Fatty (ZDF) and tested for Mfn2 
protein expression (n=3 per group).  Densitometric analyses of Mfn2/porin 
indicates that there is a 41% decrease in Mfn2 expression in ZDF rats compared 
to ZDL control (p<0.05) and no difference between ZF and ZL mice. Student’s T-
Test, *p≤0.05 
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Figure 2.2. Excision of Mfn2 leads to β-cell mitochondrial fragmentation. 
(A) β-cell mitochondria were labeled with TMRE and mito-paGFP (insulin 
promoter) for confocal imaging.  β-cells were identified by 2 photon mediated 
photoconversion of paGFP and possess fragmented mitochondria. (B) 
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Representative images showing β-cells and non β-cells (no GFP expression) from 
dispersed islets in the same field of view.  Mitochondrial fragmentation is only 
evident in the β-cells obtained from βMfn2KO samples. Cells from 3 mice were 
imaged for representative fragmentation in β-cells, all scale bars 10µm. 
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Figure 3.2. Deletion of Mfn2 in vivo and ex vivo induces altered insulin 
secretion profiles. 
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(A) No differences between WT and βMfn2KO animal body mass were observed 
at 56 days of age (n=3-4 mice per group). (B) βMfn2KO mice exhibit impaired 
glucose tolerance at 56 days of age compared to controls, *p≤0.05, n=3 mice per 
group. (C) βMfn2KO islets exhibit increased basal insulin secretion. n=7 and 8 
animals for WT and βMfn2KO respectively, performed in technical triplicates, 
p≤0.05 by student’s t-test.  (D) Acute excision of Mfn2 ex vivo increases basal 
insulin secretion. CMV-Cre infected β-cells from floxed Mfn2 mice displayed 
increased basal insulin secretion compared with CMV-GFP control infected β-cells 
(n= 3 animals per genotype; performed in triplicate). (E) No differences in insulin 
content were observed in βMfn2KO islets compared with control islets (n=3 mice 
per group; technical triplicates of 10 islets each from each animal). (F) Basal, 3mM 
glucose, Islets were perifused with Krebs buffer for 3 minutes, followed by 15mM 
glucose Krebs buffer for 30 minutes, and finally 15mM glucose + KCl 40mM 
solution for 15 minutes. βMfn2KO islets (solid line) have increased basal insulin 
secretion, a more prolonged increase in insulin secretion upon addition of 
stimulating concentrations of glucose, and display disrupted oscillatory patterns of 
secretion compared with control islets. Error bars are shown in a single direction 
for clarity. n=4 separate animals with 3 technical replicates each. (G) To further 
demonstrate the oscillatory behavior of the secretion and loss thereof in the 
βMfn2KO islets, we utilized the OOPSEG smoothing program to smooth the data 
from panel (F).  
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Figure 4.2. Mfn2 controls oxygen consumption and fatty acid metabolism in 
β-cells 
(A) Representative trace showing quantification of Seahorse traces.  (B) Basal 
oxygen consumption is 2 fold greater in islets lacking Mfn2 compared to controls 
(p<0.001, n=4 mice per group).  (C) The percent increase in oxygen consumption 
with 20mM glucose stimulation is significantly blunted in the islets lacking β-cell 
Mfn2 (p=0.002, n=4 mice per group). (D) Respiration under 5μM oligomycin, to 
block ATP synthase, is 10% greater in islets lacking Mfn2 compared to control 
(p<0.001, n=4 mice per group). (E) INS1 cells with Mfn2KD exhibit an increase in 
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palmitate induced respiration (n=4 independent experiments), Student’s T-Test, 
*p≤0.05 
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Figure 5.2. Mechanistic investigations of basal insulin secretion in β-cells 
lacking Mfn2 
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(A) Insulin secretion in response to 0.4mM palmitate. βMfn2KO animals display 
increased basal insulin secretion. When 0.4mM palmitate is added with 3mM 
glucose, βMfn2KO demonstrate a statistically significant increase in insulin 
secretion, which is not observed in control islets. Data is shown as mean ± 
standard deviation; n = 4 per group. (B) BODIPY-labeled 12-carbon fatty acid 
uptake is increased in Mfn2-KD INS-1 cells compared to scramble control cells, 
which were set at 1 for each experiment to facilitate comparison and normalization 
between experiments (p≤0.05, n=4 independent experiments). (C,D) 
Reaggregated primary islets transduced with mitochondrially targeted ORP1-
roGFP with ex-vivo Mfn2 excision, n=6 independent experiments with 8-10 islets 
per condition. Mfn2-KO (black circles) show no difference in H2O2 production at 
3mM Glu (Basal) or 15mM Glu (Stim) from the WT control (open circles). Only 
each genotype’s oxidized control (H2O2) show a significant increase (*, p≤0.05) in 
detected H2O2. All scale bars are 100μm. (E) βMfn2KO cells do not have increased 
cytosolic calcium, suggesting a mechanism not involving calcium for induction of 
insulin hypersecretion at basal levels of glucose (n=3 mice per group).  
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Figure 6.2. Scheme of progression to prediabetes via excess nutrient intake 
and mitochondrial fragmentation. 
Excess nutrient consumption (in vivo) or excess glucose/FFA (in vitro) reduced 
Mfn2 expression. The loss of Mfn2 impairs mitochondrial function and alters GSIS 
and nonstimulated insulin secretion similarly to obesity. Elevated nonstimulated 
insulin secretion leading to hyperglycemia and eventual insulin resistance is 
compounded by impaired GSIS, eventually leading to prediabetic complications. 
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Table 1.2 Krebs secretion and imaging buffer 
 
Compound 
mw 
(g/mol) 
Conc. (M) MW*con For 0.5 L 
NaCl 58.44 0.595 34.7718 17.3859 
HEPES 238.3 0.1 23.83 11.915 
KCl 74.56 0.023 1.71488 0.85744 
MgSO4 246.5 0.005 1.2325 0.61625 
Na2HPO4 141.96 0.00075 0.10647 0.053235 
KH2PO4 136.09 0.002 0.27218 0.13609 
NAHCO3 84.01 0.025 2.10025 1.050125 
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Figure S1.2. HFD mice exhibit impaired glucose tolerance after 12 weeks of 
age 
HFD mice demonstrate impaired glucose tolerance via OGTT after 12 weeks of 
age compared to control diet fed animals, n=3 animals per diet, * p≤0.05 by 
student’s t-test at each timepoint.
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Figure S2.2. Validation of beta cell specific Mfn2 knockout.  
(A) Mfn2 LoxP PCR of genomic DNA obtained from a tail blood sample and islet 
homogenate from a βMfn2KO animal. Lane 1 is the PCR product obtained using 
islet DNA as the template, the product is present at a 240bp excised band 
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demonstrating knockout of Mfn2. Any residual unexcised 810bp band is 
contributed by other cell types in the islet that would have Mfn2 excised under RIP. 
Lane 2 is the PCR product obtained using tail lysates and is present as the 
unexcised 810bp band. Lane 3 is the no template control. (B) Western blot of 
protein samples obtained from βMfn2KO and control littermate islets. Mfn2 protein 
is reduced in the islets of βMfn2KO islets and any present Mfn2 is attributed to 
non-beta cell islet cells. (C) Tissue specificity of the beta cell specific Mfn2 
knockout was measured in tissue samples obtained from a βMfn2KO mouse.  Mfn2 
expression was measured by western blot and was found to be present at varying 
degrees in all tissues tested except for isolated pancreatic islets. 
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ABSTRACT 
Mitofusin 2 was previously shown to govern basal insulin secretion and FAO in 
primary pancreatic islets. Because primary islet tissue is limited, utilizing cell lines 
as models of disease and primary tissue is beneficial. Metabolic characterization 
of cell lines provides insight into their metabolite profiles, oxygen consumption, 
ROS production, and mitochondrial function. Here, we investigated the role of Mfn2 
loss-of-function in INS-1 cells, a model of pancreatic β-cells. While adenovirally-
transduced Mfn2 siRNA reduced Mfn2 expression and fragmented mitochondria, 
it did not affect insulin secretion in either the basal or glucose-stimulated state. 
Regardless of the lack of functional consequences, INS-1 cells with Mfn2-KD 
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exhibited increased ROS production and FFA uptake, while ETC activity was 
impaired, even without reduced ETC component expression. This investigation 
paves the way for further characterization of mitochondrial fragmentation and its 
consequences, particularly fusion-independent functions of Mfn2 utilizing 
modulators of its activity. 
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INTRODUCTION 
Metabolism sits at the intersection of environment and genetics, and as 
such serves as a hub to investigate cellular and mitochondrial dysfunction. Here 
we describe a systematic approach to metabolic phenotyping in a model of 
pancreatic beta cells for the study of mitochondrial fragmentation. Given the 
pancreatic beta cell’s unique position as a nutrient signal integrator, 
characterization of its nutrient breakdown is critical to understanding its function. 
Prior work from our lab has shown that mitochondrial morphology is both governed 
by available fuel and alters cellular metabolism (Molina et al., 2009; Twig et al., 
2008; Wikstrom et al., 2007). Because mitochondria fragment in response to 
obesity and diabetes (Molina et al., 2009), we induced fragmentation via an 
adenovirally-delivered shRNA for Mitofusin 2 (Mfn2-KD) and characterized the 
metabolic consequences thereof. 
Previous studies focusing on Mfn2 loss of function have focused on other 
cell types, such as mouse embryonic fibroblasts (H. Chen, Chomyn, & Chan, 2005) 
and skeletal muscle (Pich et al., 2005) and demonstrate that Mfn2 independently 
regulates both mitochondrial dynamics and metabolic activity in mitochondria, as 
evidenced by the glucose oxidation-enhancing effects of overexpression of a 
fusion-incompetent truncated Mfn2 (Pich et al., 2005). Because knockout of Mfn2 
resulted in a greater sensitivity to palmitate-induced insulin secretion at 
nonstimulatory glucose concentrations (Ch. 2), we further investigated the 
consequences of Mfn2 loss-of-function. In this study, we focused on some of the 
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most likely modulators of insulin secretion in response to mitochondrial 
fragmentation: ROS (Pi et al., 2007), mitochondrial mass and function (Molina et 
al., 2009; Patterson et al., 2014; Wikstrom et al., 2007), and fatty acid metabolism 
(Christopher J Nolan et al., 2006). 
Oxygen consumption measurement can provide information on fuel 
dependence, metabolic efficiency, and can be used in conjunction with other 
techniques to derive flux through metabolism, for instance measuring oxygen 
consumption in response to fatty acid stimulation. Oxygen consumption 
measurements also provide information such as mitochondrial inner membrane 
leak and non-mitochondrial oxygen consumption.  
Given the importance of the mitochondria to the cell and our previous work 
showing the disruption of mitochondrial dynamics, particularly fusion (Molina et al., 
2009), and the role of mitofusin 2 (Mfn2) in the response to excess nutrients (Ch. 
2) we knocked down Mfn2 in INS-1 cells (Asfari et al., 1992) to investigate their 
metabolic response to mitochondrial fragmentation. By using an adenovirally-
delivered siRNA, we were able to investigate the effects of an acute reduction in 
Mfn2 in a beta cell line and determine its functional consequences on the cells.  
 
MATERIALS AND METHODS 
Viral Transduction of Mfn2-siRNA (Mfn2-KD) 
An siRNA-containing Adeno-associated virus was purchased from Welgen 
(Cambridge, MA) containing mKate2 as a marker of transduction. The effective 
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multiplicity of infection (MOI) was determined by high-throughput imaging of cells 
treated with increasing MOIs of virus and measurement of mKate2 fluorescence. 
The MOI of the KD virus was determined to be 200 for >90% transduction 
efficiency and 1700 for the scramble control (SCR). The large difference between 
these MOIs is a result of the quantification of viral particles performed by Welgen. 
The concentration of particles is measured optically, not as plaque-forming units, 
meaning each virus can have different portions of active viral particles. 
Cell Culture 
INS-1 cells were plated at 10,000 cells per well in 100uL in the presence of 
MOI 200 (KD) or MOI 1700 (SCR) on 96-well plates (Corning #3603) for high 
throughput imaging. A Seahorse utility plate was utilized for respirometry; cells 
were plated at a density of 2,000 cells per well in 150uL. Six-well plates were used 
for metabolomic experiments and plated at a density of 500,000 cells per well in 
2mL of media. The cells were cultured in INS-1 medium overnight with the virus, 
then given fresh media the following day. The cells grew out for an additional 3 
days (37°C, 5% CO2), at which point they were assayed. 
High Throughput imaging 
Cells were washed with Imaging Media without phenol red once, then 
stained with Hoechst nuclear dye (1μg/mL) and one of the following: DHE (10 μM), 
Mitotracker Green (200 nM), or BODIPY 533 (200 nM) for 45 minutes, after which 
they were washed twice with imaging media and immediately imaged on an 
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Operetta high content imager. The separation of various dyes was necessary due 
to spectral overlap with each other. Each genotype was imaged in triplicate. The 
DHE stained cells were imaged first due to the time-sensitive nature of this 
irreversible ROS probe. 
Fatty acid uptake measurements 
INS-1 cells transduced with adenoviral shRNA (Welgen, MA) overnight 
were cultured for 3 days to knockdown Mfn2. Mfn2-KD INS1 cells were incubated 
for 45 min with 200nM C12-BODIPY 558/568 in 11mM glucose RPMI (0.1% FBS), 
after which the media containing BODIPY-labeled FAs was removed, fresh, 
phenol-red-free DMEM media (1% FBS) was placed on the cells, and the cells 
were imaged in an Operetta high-content imager at 37°C with 5% CO2 to evaluate 
BODIPY fluorescence inside the cells. These images were then quantified using 
the Operetta Harmony software for average cytosolic fluorescence after 
thresholding and removing background. 
Image Analysis 
Images were analyzed in the Operetta Harmony software, which was used 
to quantify fluorescence intensity of these dyes plus identification of transduced 
cells via mKate2, the reporter included with the adenovirus used for transduction. 
Confocal Imaging 
INS-1 cells were plated on Quadrant confocal dishes and imaged on a Zeiss 
LSM-880 microscope with a 63X oil immersion objective (1.4 NA) equipped with 
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an Airyscan detector (Weisshart, 2014). Prior to imaging, cells were stained with 
mitotracker green for 45 min and washed thrice. The reporter fluorophore mKate2 
was used to identify transduced cells. Images were quantified using FIJI 
(www.fiji.sc) for mitochondrial architecture. 
Respirometry 
The Agilent Seahorse XF96 Extracellular Flux Analyzer was utilized to 
measure oxygen consumption from Mfn2-KD and SCR control cells. Drug 
concentrations were as follows: oligomycin (5μM), FCCP (1μM), rotenone (5μM) 
and antimycin A (5μM) (Sigma). The protocol for mitochondrial stress analysis was 
followed as published (Nicholls et al., 2010; Seahorse, 2017). Data were compiled 
and analyzed in Seahorse Wave and Graphpad Prism softwares.  
 
Metabolomics 
The experiments were performed as described in (Thai et al., 2014). Briefly, 
cells were seeded in 6 well plates, so that the final cell count at the time of 
metabolite extraction was about 7*105 and even across all cell lines. Medium was 
changed with medium containing U-13C-glucose or U-13C glutamine 24h before 
metabolite extraction. To extract intracellular metabolites, cells were briefly rinsed 
with cold 150 mM ammonium acetate (pH 7.3), followed by addition of 1 ml cold 
80% MeOH on dry ice. Cells were detached with cell scrapers, suspensions 
transferred into Eppendorf tubes and 10 nmol D/L-norvaline was added. After 
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rigorously mixing, the suspension was pelleted by centrifugation (1.3*104 rpm, 4 
°C). The supernatant was transferred into a glass vial, metabolites dried down 
under vacuum, and resuspended in 70% acetonitrile. For the mass spectrometry-
based analysis of the sample, 5 µl were injected onto a Luna NH2 (150 mm x 2 
mm, Phenomenex) column. The samples were analyzed with an UltiMate 
3000RSLC (Thermo Scientific) coupled to a Q Exactive mass spectrometer 
(Thermo Scientific). The Q Exactive was run with polarity switching (+3.50 kV / -
3.50 kV) in full scan mode with an m/z range of 65-975. Separation was achieved 
using A) 5 mM NH4AcO (pH 9.9) and B) ACN. The gradient started with 15% A) 
going to 90% A) over 18 min, followed by an isocratic step for 9 min and reversal 
to the initial 15% A) for 7 min. Metabolites and isotopomers thereof were quantified 
with TraceFinder 3.3 using accurate mass measurements (≤ 3 ppm) and retention 
times. For isotopologue distribution measurements, data was corrected for 
naturally occurring 13C as described (Moseley, 2010). Data analysis, including 
principal component analysis and hierarchical clustering was performed using the 
statistical language R. Fractional contributions were calculated using the formula 
𝐹𝐶 =
∑ 𝑖∗𝑚𝑖
𝑛
0
𝑛 ∑ 𝑚𝑖
𝑛
0
 as described (Fendt et al., 2013), where mi denotes the intensity of the 
isotopologue, and n marks the number of carbons in a given metabolite. 
Insulin secretion 
INS-1 cells at 60-80% confluence were incubated for 2hr in 2mM glucose 
RPMI culture media (37°C, 5% CO2) then incubated in 2mM glucose secretion 
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buffer for a 1hr pre-incubation in a 37°C water bath, ensuring the water was in 
contact with the bottom of the plate for efficient heat transfer. Following this pre-
incubation, the cells were incubated in the respective conditions (in triplicate) for 
45min in a 37°C water bath for insulin secretion, with 2mM glucose as basal and 
12mM glucose as stimulated insulin secretion. The media was collected from the 
wells and insulin content measured by the HTRF Insulin Assay (Cisbio Bioassays). 
Data was normalized to cell counts per well imaged on the Operetta and 
calculations performed in Graphpad Prism. 
Insulin Measurements 
An HTRF insulin assay kit was used to measure insulin secretion (CisBio, 
Bedford, MA). The assay consists of a FRET-based sandwich immunoassay with 
Europium Cryptate (Eu-K) and allophycocyanin (XL665) antibodies. Secretion 
samples were appropriately diluted in a 96-well plate after which 5uL of sample 
and 5uL of the antibody mix were dispensed into white 384-well plates (#784076, 
Greiner Bio-One), which was protected from light with aluminum foil and incubated 
overnight at room temperature. Wavelengths are expressed as wavelength 
(bandwidth). A Tecan Infinite M1000 or Spark 10M plate reader was used to 
measure time-resolved fluorescence at 317(20)nm excitation and emission 
wavelengths of 665(20)nm (XL665) and 620(20)nm (Eu-K). Insulin concentration 
of the samples was calculated from an insulin standard curve in the same plate. 
Values that did not fall within the standard curve were excluded. 
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RESULTS 
Knockdown of Mfn2 fragments mitochondria 
Adenovirally-delivered shRNA for Mfn2 results in fragmented mitochondrial 
morphology compared to the Scrambled (SCR) control in INS-1 cells (Fig 1.3A). 
Super-resolution images show mKate2, the marker of transduction in the cytosol, 
and mitotracker green localizes to mitochondria. Transduction efficiency in all 
conditions exceeded 90% (Fig 1.3B), and transduction of the shRNA did not affect 
cell growth significantly (Fig 1.3C). 
 
Knockdown of Mfn2 does not change mitochondrial mass 
We utilized the Operetta high content imager in order to investigate the 
consequences of limiting mitochondrial fusion on mitochondrial mass, measured 
as the average intensity of mitotracker green per cell (Fig 2.3A).  Even though 
mitochondrial dynamics is essential for mitochondrial quality control, mitochondrial 
mass was unchanged (Fig 2.3B). It is possible that the relatively short time course 
of these experiments (72-96 hr) was insufficient to induce dysfunction of 
mitochondrial quality control and exert an effect on mitochondrial mass. 
Knockdown of Mfn2 Increases labeled fatty acid uptake 
Mfn2-KD INS-1 cells were incubated for 45 minutes with 12-carbon Bodipy-533, 
which enters cells in a manner similar to 16-carbon fatty acids. Average 
fluorescence intensity per cell was quantified as a measure of uptake. Previous 
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publications have shown this labeled fatty acid is degraded in a regular fashion 
and traffics in a manner similar to unlabeled fatty acids (Rambold, Cohen, & 
Lippincott-Schwartz, 2015), and Mfn2-KD INS-1 cells exhibited significantly 
increased FFA uptake (Fig 2.3C). 
Knockdown of Mfn2 increased ROS production 
Given the arrest of mitochondrial dynamics that accompanies loss of fusion, Mfn2-
KD cells were incubated with dihydroethidium (DHE) for 45 minutes and then 
imaged with the Operetta high content imager (37°C, 5% CO2). We observed a 
significant increase in DHE positive cells with Mfn2-KD compared to the SCR 
control, suggesting an increase in ROS production as a result of the reduction in 
Mfn2 expression (Fig 2.3D). This is consistent with other studies showing reduced 
mitochondrial activity and increased ROS production from HeLa cells using a 
similar shRNA approach to knockdown Mfn2 (Ding, Gao, Zhao, Wang, & Zheng, 
2015). In HeLa cells, this increased ROS production is the result of dysfunctional 
mitochondria accumulating in the cytosol due to impairment of mitophagy, a 
mechanism that could also explain our results here.  
Insulin secretion from Mfn2-KD cells is unchanged 
Both basal (2mM glucose) and Glucose Stimulated (12mM glucose) insulin 
secretions were unaffected in the Mfn2-KD cells (Fig 2.3E). This phenotype was 
unexpected because in primary β cells basal insulin secretion is significantly 
increased with the loss of Mfn2 (Ch. 2). This functionally different response in 
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primary cells and a model thereof led us to investigate why these two systems 
exhibit different phenotypes. 
Mfn2-KD reduces overall oxygen consumption in INS-1 cells 
Loss of Mfn2 expression significantly reduces basal oxygen consumption (Fig 
3.3A) as well as oligomycin-resistant oxygen consumption, which is proton leak 
across the inner mitochondrial membrane (Fig 3.3B). In addition, ATP linked 
oxygen consumption (Fig 3.3C) and maximal respiration (Fig 3.3D) are decreased. 
This result, paired with the increased ROS production above, suggest cells with 
early mitochondrial dysfunction that has not manifested other functional effects 
such as impaired insulin secretion. The reduced oxygen consumption in Mfn2-KD 
cells suggested possible substrate handling deficiencies in Mfn2-KD cells, which 
we investigated using footprint and metabolomics approaches.  
Mfn2-KD does not change TCA substrate uptake 
In order to investigate the changes in substrate uptake, we used the Nova 
Bioanalyzer and did not observe a difference between the knockdown and 
scramble conditions in glucose utilization (Fig 4.3A), glutamate production (Fig 
4.3B), or glutamine production (Fig 4.3C). The Mfn2-KD exhibited a trend of more 
glutamine production that was insignificant upon statistical analysis. Thus, it 
appears that Mfn2-KD INS-1 cells respond to fragmentation with a decrease in 
respiration and no change in oxidized substrate preference, regardless of the 
increased uptake of labeled fatty acids. 
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Mfn2-KD alters metabolite profiles in INS-1 cells 
Utilizing universally-labeled 13C-Glucose, we performed tracing experiments for 
the carbons derived therefrom. When analyzed by mass spectrometer, we 
observed an increase in Phosphocreatine. This increase could be a storage 
mechanism for high-energy phosphates derived from additional flux through the 
ETC, as shown previously in neurons (Meyer et al., 2006). 
Mfn2-KD reduces ETC activity without reducing mitochondrial ETC protein 
Upon knockdown of Mfn2, we observed no change in expression of several ETC 
components when quantified by densitometry of western blots using FIJI (Fig 5.3). 
However, the ATP/ADP ratio was unaffected, suggesting an overall reduction in 
high-energy adenosine nucleotides. This finding is similar to previous findings in 
heart tissue with Mfn2KO, suggesting a common governing mechanism between 
these two metabolically demanding tissues (Mourier et al., 2015). 
DISCUSSION 
Mfn2 was shown in the previous chapter to have a functional role in 
regulation of insulin secretion. As a result of these findings, we set out to determine 
the mechanism of this regulation in a pancreatic β-cell line utilizing high-throughput 
techniques. Knockout of Mfn2 in primary beta cells increased basal insulin 
secretion and basal respiration, in addition to more fatty acid oxidation (Ch. 2). 
INS-1 cells are frequently used as a pancreatic beta cell model (Asfari et al., 1992; 
Molina et al., 2009; V Poitout, Olson, & Robertson, 1996; Roduit et al., 2004; 
Skelin, Rupnik, & Cencic, 2010; Wikstrom et al., 2007). However, we observed no 
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change in insulin secretion between the Mfn2KD and SCR groups. Perhaps this 
disparate phenotype between the two is the result of a knockout versus knockdown 
of Mfn2. Alternatively, INS-1 cells are immortalized for cell culture, which have a 
different glucose metabolism when compared to primary tissue models. 
Regardless of the mechanism for the difference, we have demonstrated that 
knockdown of Mfn2, validated by imaging and western blots, affects mitochondrial 
morphology without significantly changing insulin secretion.  
Mfn2-KD increased ROS formation and FFA uptake independent from altering 
insulin secretion 
 Mfn2-KD cells exhibited increased FA uptake, which suggests an alteration 
in fuel preference in INS-1 cells. Thus, even in the absence of a functional change 
in GSIS, forced mitochondrial fragmentation by Mfn2 knockdown induced a fuel 
switch and decreased oxygen consumption, similar to previous findings in HeLa 
cells with Mfn2 knockdown induced via shRNA (Ding et al., 2015).  
ROS have been shown to be instrumental to insulin secretion (Pi et al., 
2007), in addition to being increased in excess nutrient conditions and stress 
(Criddle et al., 2006). Because insulin secretion was increased in primary β-cells 
in Ch. 2, we investigated the effect of Mfn2-KD on ROS production. Interpretation 
of ROS measurements presents challenges, particularly for the probe DHE 
(Laurindo, Fernandes, & Santos, 2008). However, this probe was specifically 
chosen because interpretation of results can be aided in the future by HPLC and 
quantification of specific oxidized products, such as ethidium and oxyethidium. 
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Separation of these two fluorescent products provides more accurate information 
of what ROS species oxidized DHE (Fink et al., 2004; Laurindo et al., 2008; 
Nazarewicz, Bikineyeva, & Dikalov, 2013; Tollefson, Kroczynski, & Cutaia, 2003). 
While this granularization was not performed on the samples in this project, such 
methods are well-suited to a high-throughput screening approach, because many 
other utilized techniques overlap with the tools needed for column separation of 
metabolites for metabolic screening. Further investigations should include 
quantification of the oxidized products to elucidate their electron donors, which 
may further illuminate the source of increased ROS production in Mfn2-KD cells.  
This change in morphology without alterations in function certainly warrants 
further investigation. Perhaps Mfn2 is the primary link between morphology and 
metabolism, in such a way that low levels of expression after knockdown are 
sufficient to preserve “normal” metabolism observed in WT INS-1 cells. Other labs 
have shown that Mfn2 affects metabolism independently of its fusion activity (Pich 
et al., 2005), which means these two functions are functionally distinct. A possible 
explanation for this differential behavior could be the necessary dimerization of 
Mfn’s for fusion activity, meaning the Mfn oligomers may be functionally distinct 
from monomers. An alternative hypothesis is that INS-1 cells modulate insulin 
secretion in manners dissimilar from primary β-cells. Future experiments should 
investigate not only additional manipulations of morphology by changing Drp1, 
OPA1, or Mfn1 expression, but also include the truncated, fusion-incompetent form 
of Mfn2 or other modulators of mitofusin activity such as small peptides (Franco et 
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al., 2016). In addition, further investigation of the difference between immortalized 
cell models and their primary counterparts, specifically beta cells, will provide 
better quality control to the field of obesity research because of the important role 
mitochondria and metabolism play in pathology.  
 
 
 
 
 
  73 
 
Figure 1.3.  Mfn2 Knockdown results in fragmented mitochondria and does 
not change cellular proliferation. 
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(A) Mitochondrial fragmentation is evident 72 hours after transduction with Mfn2 
shRNA knockdown adenovirus, mKate2 used as marker of transduction. (B) 
Transduction efficiency for both conditions exceeded 90% and (C) did not affect 
cellular proliferation significantly in the timeframe studied. Error bars represent 
SEM for 3 independent experiments, *p≤0.05 by student’s t-test. 
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Figure 2.3.  High-throughput imaging of Mfn2KD INS1 cells reveals metabolic 
differences without functional consequences. 
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(A) High-content images acquired on the Operetta High Content Imager (Perkin 
Elmer), showing nuclei (Hoechst), transduction efficiency (mKate2), mitochondrial 
mass (mitotracker green), ROS production (DHE), and FFA accumulation 
(BODIPY-568). Note the fields for DHE and BODIPY-568 are from different wells 
than the other images due to spectral overlap of the probes. (B) Mfn2-KD cells do 
not have altered mitochondrial mass, but do exhibit changes in fluorescently 
labeled FA uptake (C) and ROS production (D). Despite these metabolic 
differences, Mfn2KD cells are functionally similar to the SCR control when 
evaluating GSIS (E). Error bars represent SEM for 3 independent experiments, 
*p≤0.05 by student’s t-test. 
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Figure 3.3.  Mfn2KD cells exhibit reduced mitochondrial activity.  
Mfn2KD INS1 cells demonstrate significantly reduced oxygen consumption, 
including (A) basal oxygen consumption, (B) proton leak, (C) ATP-linked 
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respiration, (D) maximal oxygen consumption. These changes do not alter 
bioenergetic efficiency, a measurement of basal respiration per proton leak 
(oligomycin-resistant respiration). (E). Error bars represent SEM for 3 independent 
experiments, *p≤0.05 by student’s t-test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  79 
 
Figure 4.3. Substrate uptake and nontargeted metabolomics reveal 
nonsignificant differences between Mfn2KD and SCR cells.   
Mfn2-KD cells do not significantly alter nutrient uptake compared to SCR controls 
in a 24 hour period compared to SCR controls, including glucose uptake (A), 
Glutamate Production (B), or Glutamine production (C). Error bars represent SEM 
for 3 independent experiments, *p≤0.05 by student’s t-test. 
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Figure 5.3.  Mfn2KD cells maintain ETC machinery in the face of reduced 
respiration. 
(A) Representative blots of ETC proteins; (B) through (D) are Mfn2KD INS-1 cells 
do not alter ETC component expression when compared to their SCR controls, 
despite the impaired respiration in Fig. 3.3. Error bars represent SEM for 3 
independent experiments, *p≤0.05 by student’s t-test.
  81 
CHAPTER FOUR: High-Throughput Quantification of Mitochondrial 
Morphological Parameters in Brown Adipose Tissue Using Advanced Image 
Segmentation 
Nathanael Miller *,1,2, Dane Wolf *,1,2, Nour Alsabeeh1,2, Kiana Mahdaviani2, Orian 
Shirihai1 
 
*Equal contributions from these authors 
1. Division of Endocrinology, Department of Medicine, David Geffen School of 
Medicine at UCLA, Los Angeles, CA, USA  
2. Obesity Research Center, Department of Medicine, Boston University School of 
Medicine, Boston, MA, USA  
 
ABSTRACT 
 
Digital image analysis of high-resolution micrographs is a challenging field that 
provides vast amounts of data. Here, we describe a novel method of segmenting 
Brown Adipose Tissue (BAT) that provides a granular approach to quantifying 
subcellular structures, particularly mitochondria in relation to lipid droplets. In 
addition, we lay out a novel machine-learning based mitochondrial segmentation 
method that eliminates the bias of manual mitochondrial segmentation and 
improves object recognition compared to conventional thresholding analyses. By 
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applying these methods, we discovered a significant difference between cytosolic 
and peridroplet BAT mitochondrial H2O2 production, and validated the machine 
learning algorithm in BAT via norepinephrine-induced mitochondrial fragmentation 
and comparing manual analyses to the automated analysis. 
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INTRODUCTION 
 Image acquisition and analysis are critical tools for the quantification of 
mitochondrial parameters. Imaging data can provide not only morphological 
measurements(Joshi, Crouser, Julian, Schanbacher, & Bauer, 2000), but also 
membrane potential (ΔΨ), mitochondrial mass, ROS production, and calcium, 
among others. A major challenge facing the microscopist is the quantification of 
imaging data without biasing the results of the study. Automated image analysis 
provides an unbiased, repeatable, and high-throughput method to quantify high-
resolution micrographs. The use of macros (a set of instructions for a computer to 
perform repeatedly) is the most amenable way to increase image analysis 
throughput with current tools (Mutterer & Rasband, 2012). A macro reduces the 
amount of time to analyze a single image while ensuring that subsequent images 
are analyzed in an identical manner.  
Brown Adipose Tissue (BAT) provides a unique case due to its high density 
of (frequently overlapping) mitochondria in the cytosol packed tightly with and 
around lipid droplets. Previous work in other cell types has focused on quantifying 
the entire network or manual classification of network morphology (Cribbs & 
Strack, 2009; Leonard et al., 2015; Mahdaviani et al., 2017; Valente, Maddalena, 
Robb, Moradi, & Stuart, 2017), while this work focuses on direct quantification of 
individual mitochondria. Improvements in computer processing power and 
graphical handling enable a novel solution to this difficult problem: machine 
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learning. Simply, machine learning is the process of humans training a computer 
program to perform a task. This differs from programming because the underlying 
architecture for decision-making has been written by a programmer and the human 
trainer simply segregates objects into different classes (bins, types of objects, etc.), 
which the computer then analyzes to build a decision tree to arrive at a similar 
classification scheme as the human trainer. This type of machine learning is 
referred to as a random forest model and is one of many iterative machine learning 
algorithms (Breiman, 2001).  
Due to considerations of cost and transparency, the open-source programs 
ImageJ (https://imagej.nih.gov/ij/) and its plugin-rich counterpart FIJI (Schindelin 
et al., 2012) (http://fiji.sc/) are utilized for these analysis protocols and data. FIJI 
provides several plugins not available in stock ImageJ that greatly expedite 
analysis. Chief among these tools is the WEKA trainable segmentation plugin 
(Arganda-Carreras et al., 2017), which enables rapid training and deployment of 
machine-learning segmentation protocols. Tools of this nature are incredibly 
resource intensive and, as such, must be used on computers with sufficient 
processing and graphical power. Both ImageJ and FIJI are open-source and widely 
documented, providing ideal tools for scientific use. 
Similar tools have previously been utilized to quantify mitochondria, albeit 
in a more limited manner. Koopman et al. introduced the concept of using a 
machine learning classifier to morphologically characterize and bin mitochondria 
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(Koopman, Visch, Smeitink, & Willems, 2006). This technique has been further 
refined by other groups (Leonard et al., 2015; Valente et al., 2017). Both of these 
approaches did not fully quantify mitochondrial morphology, but rather quantified 
the population of each type of mitochondrion, e.g. tubular vs. punctate. Previous 
work has also described what parameters best define mitochondrial morphology 
(Joshi et al., 2000). While the conventional approach of manual thresholding for 
segmentation is valid, it is subject to the analysts’ bias (Cribbs & Strack, 2009). 
Combining these above approaches – using machine-learning to segment 
mitochondria which are then individually quantified using established parameters 
– provides the most robust and accurate quantification to date. Software exists to 
perform a similar segmentation routine (Harwig et al., 2018), but it is not easily 
adaptable as an ImageJ script, while the methods provided here are cross-platform 
and usable within ImageJ or FIJI. Additionally, the data outputs from these two 
methods are not identical and may in fact complement each other. 
These tools are significantly more effective when the input micrographs are 
of high quality and resolution. Poor signal-to-noise ratio, low fluorescence in 
samples, and many other caveats of fluorescent microscopy influence the efficacy 
of image analysis. A recent publication details the ideal input image quality and 
common problems and artifacts encountered with analyses of this type (Harwig et 
al., 2018). The methods contained herein provide tools to segment and quantify 
lipid droplet number, morphology, and intensity in brown adipocytes (BAT). We 
also describe a novel approach to segment mitochondria within these same cells 
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in order to investigate mitochondria immediately adjacent to lipid droplets versus 
mitochondria in the rest of the cytosol. While such granulated approaches have 
been performed in the past (Glancy et al., 2015), they were undertaken in muscle 
tissue and revealed a novel energy conduction pathway along a mitochondrial 
network. Here we show a phenotypic difference between mitochondria 
immediately adjacent to the lipid droplet and the mitochondria distributed within the 
cytosol. Moreover, we provide a method for improved mitochondrial segmentation 
and measurement via the WEKA trainable segmentation plugin. Not only is this 
approach different from previous mitochondrial machine learning classification 
schemes (Leonard et al., 2015), but it provides an open and transparent tool with 
the potential to be refined and improved. The development of a WEKA classifier 
for mitochondrial segmentation expands the available input images significantly; a 
WEKA classifier is much better at segmenting poorly-acquired images than most 
conventional methods, preventing the issues mentioned above from excluding 
images from analysis. More importantly, input images from lower quality 
microscopes are generally accepted and properly segmented, assuming sufficient 
quality. 
The method contained herein has been validated on images from several 
different microscopes and collection tools, but all images were in focus and 
sufficiently magnified that a human could recognize individual mitochondria within 
the cytoplasm of the cell. This level of detail is generally acquired by an objective 
lens of 60X magnification or higher, with a NA of 1.4. All images were initially 
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acquired with at least 1024 x 1024 pixels. The high resolution images permit 
detailed manual cropping of the cell from its field of view, a necessary step to 
ensure robust segmentation of mitochondria. More detailed metadata of the 
images used in this method are contained in the methods.  
Brown adipocytes provide an ideal test case for these tools. Not only do the 
mitochondria in the cytosol differ from those surrounding lipid droplets (Benador et 
al., 2018), but also BAT mitochondria fragment upon norepinephrine-induced 
thermogenesis (Wikstrom et al., 2014), meaning accurate quantification of these 
phenomena can demonstrate the validity of our analysis protocols. 
MATERIALS AND METHODS   
Viral Transduction of ROS reporters 
Mitochondrially-targeted Orp-1 roGFP (Morgan et al., 2011) was 
adenovirally transduced into primary BAT isolated from 12-16 week old C57BL/6J 
mice overnight at a MOI of 2000 particles per cell. This resulted in >90% 
transduction. After an overnight incubation at 37°C and 8% CO2, the cells were 
given fresh media without viral particles and cultured for 72 hours prior to imaging. 
Microscopy 
Images of BAT were obtained on a Zeiss LSM 710 or LSM880 microscope 
equipped with a plan-apochromat 100X (NA=1.4) oil immersion objective. Images 
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were taken with a digital zoom of 1 or above. Images were at least 1024 x 1024 
px.  
Validation of machine learning classifier 
The WEKA segmentation classifier was validated for several cell types 
(hepatocytes and INS-1 data not shown, BAT included) against human recognition 
of objects. Briefly, a human created ROIs manually around each mitochondrion in 
a cell, usually more than 100 mitochondria per cell. These individual regions were 
quantified identically to the WEKA-generated or threshold-generated ROIs of the 
same cells. All three analyses performed by the same human and they manually 
thresholded at a level that facilitated object recognition, typically ~10% of the 
maximum fluorescence intensity. 
All images were high resolution images of single cells cropped from a larger 
field of view. This cell-level analysis facilitates granular analysis of the data and 
examination thereof on a cell by cell basis. 
Training images used for WEKA training set 
Images used for training of the classifier were high resolution and super 
resolution micrographs at resolutions above 512 x 512 px. Training was performed 
on manually cropped individual cells from different fields of view, more than 4 
independent experiments, and on 2 different fluorescence markers of 
mitochondria: mitotracker green and TMRE. This broad training set increased 
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accuracy and flexibility of segmentation. Input images for segmentation should be 
of as high resolution as possible, but maximum pixel size utilized for analysis was 
0.07 µm per px. Some enhancements can improve poor quality images for 
analysis, such as a previously published filtering method utilizing a median filter 
(Smith, Kovats, Lee, & Cano, 2006) or utilizing built in background subtraction in 
ImageJ, such as the rolling ball algorithm. Figures 3.4 and 4.4 illustrate lower-
quality, lower-resolution (0.165 µm per px) images that are still accurately 
segmented by the classifier. 
RESULTS 
Mitochondrial morphological parameters describe mitochondrial networking 
Image analysis frequently measures fluorescence intensity, both for 
quantification and sorting of cells. Additional commonly-measured parameters 
include area and perimeter of the region of interest (ROI). As previously 
established (Joshi et al., 2000; Koopman et al., 2006; Leonard et al., 2015; Molina 
et al., 2009; Nguyen, Beyersdorf, Riethoven, & Pannier, 2016; Twig et al., 2006; 
Wikstrom et al., 2007), mitochondrial morphology can be described by various 
shape descriptors (Table 1.4). Chief among these shape descriptors is the 
circularity measurement (Circ), which compares the perimeter of the region of 
interest to the perimeter of a perfect circle of the same area. This measurement is 
primarily used to describe branching of the network, because it equals 1 when 
measuring a perfect circle, and much less than 1 for a starfish shape. Form factor 
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(FF) is another frequently used shape descriptor, and is simply the inverse of 
circularity, meaning a starfish shape has a FF much greater than 1, while a perfect 
circle still has a FF of 1. Another frequent shape descriptor used for analysis of 
mitochondrial morphology is the aspect ratio (AR). AR measures the ratio of the 
long axis length of the ROI to the short axis length, and is a measure of elongation 
of the object. Solidity measures the concavity of the ROI, which can also be 
interpreted as branching or connectivity. Utilizing these parameters, mitochondria 
may be described in morphological as well as fluorescent detail. 
Segmentation of cytosolic mitochondria versus peridroplet mitochondria reveals 
significant differences in H2O2 production 
Brown adipose tissue (BAT) is specialized to utilize energy to produce heat 
upon activation by norepinephrine (Wikstrom et al., 2014). This specialization 
depends heavily on mitochondrial dynamics. Cell biologists have hypothesized 
(Wikstrom et al., 2007) that mitochondria may specialize into different populations 
within a cell, but evidence for this hypothesis is rare due to the difficulty of 
segmentation for analysis. A previous publication has supported this hypothesis in 
muscle, (Glancy et al., 2015) but other cell types remain to be analyzed in such a 
way. For instance, a question of interest is: How different are peridroplet 
mitochondria from their cytosolic counterparts? The analysis of these images 
proved to be challenging – how does one segment mitochondria in the cytosol 
apart from mitochondria immediately surrounding lipid droplets? By selectively 
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labeling lipid, we can visualize the droplets in order to segment the mitochondria 
around them. While this approach is somewhat limited in its morphological 
analysis, an additional level of subsegmentation could be added in order to 
separate each mitochondrion from its neighbors and measure each one’s 
morphology in addition to measuring the average fluorescence intensity of the 
whole population. Here, we demonstrate a novel segmentation method for BAT 
mitochondria using a lipid label as the seed for the analysis.  
The original image contains 4 channels, not all of which are useful to the 
analysis: Nile red (lipid), ORP1-roGFP (redox status, 2 channels), and bright field 
(BF). The BF channel is immediately discarded upon beginning analysis; it is a 
quality control channel included for manual review. The roGFP probe is a redox 
sensitive GFP fused to ORP1, which is itself a H2O2-specific antioxidant enzyme 
from yeast, making this probe a tool to measure H2O2 production in the 
mitochondrial matrix (Morgan et al., 2011). Nile Red is a lipophilic dye that marks 
lipid compartments selectively; it is used to locate and segment lipid droplets within 
BAT cells.  
In order to evaluate cytosolic versus peridroplet mitochondria, the first step 
is to segment the lipid regions, which is accomplished with a basic automated 
thresholding step (Otsu method). This binarized image is then used for several 
other operations within the analysis. First, it is used to subtract the small amount 
of fluorescence bleed-through from Nile red into the reduced roGFP channel. 
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Second, it is used as the seed for peridroplet-mitochondria recognition. This 
segmentation is accomplished by dilation of the lipid region n times, where n is 
user-defined at the outset of analysis. This step is user-defined because of several 
considerations, primarily due to artifacts resulting from diverse input images. 
Because images may be taken at different magnifications and metadata is not 
always present to convert pixel units to SI units, allowing the user to define the 
peridroplet region in pixel units removes potential bias and bugs from the analysis 
itself while providing extensive customization for various inputs. After dilation and 
automated segmentation, the region immediately surrounding the lipid droplet is 
measured. 
After the peridroplet region is measured, the dilated lipid image is used to 
subtract all peridroplet fluorescence from the cytosolic image, leaving only objects 
not analyzed in the previous step. This cytosolic image is then automatically 
thresholded using the MinError method in FIJI, then segmented using the “analyze 
particles” tool. This segmented image is then measured for the cytosolic data. 
Once these measurements are saved as a .csv file, they can be handled like other 
data arrays in various programs. 
When segmented to recognize separate subcellular populations of 
mitochondria, we found that cytosolic mitochondria produce significantly more 
H2O2 than peridroplet mitochondria (Fig 2.4). The addition of menadione, a 
mitochondrial toxicant that induces ROS formation via redox cycling (Criddle et al., 
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2006) was used as a positive control and elicited a significant increase in H2O2 
production in treated cells.  
Trainable WEKA segmentation is significantly more effective at mitochondrial 
segmentation compared to conventional thresholding methods 
Trainable WEKA segmentation is a plugin for FIJI that enables machine-
learning based image segmentation. Previously, work has focused on classifying 
and counting mitochondria using machine learning (Leonard et al., 2015), but this 
approach outputs much less useful data than possible. Frequently, these 
approaches only provide counts of objects contained in each class. With these 
known limitations, we set out to 1) improve mitochondrial segmentation for analysis 
and 2) utilize machine learning in a novel way to that end. 
Machine learning is a complex field with many different algorithms available, 
each with tradeoffs between speed, accuracy, processor utilization, and other 
system requirements. The FastRandomForest (Breiman, 2001) algorithm attempts 
to mitigate some of the system requirements and speed up computation, which is 
part of why it is commonly used in this context. To the user, the algorithm is mostly 
a backend affair, and once selected is not seen again during training. WEKA 
provides a graphical user interface (GUI) useful for training a classifier. Within this 
GUI, the user defines the number and names of each class to be trained (in this 
example, the two classes are “mitochondria” and “background”). After defining and 
naming classes, the user trains the classifier, which entails using any of FIJI’s 
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selection tools (line, rectangle, circle, etc.) to define regions of an image belonging 
to a certain class. In Figure 3.4, this iterative process is demonstrated while training 
the classifier to distinguish mitochondrial signal from background noise. Panel F 
represents the final classification of the image, showing mitochondria in red and 
background in green. The final set of instructions for segmentation are stored in a 
file called a classifier with extension “.model” This published classifier is the 
product of over 100 training images containing tens to hundreds of discrete data 
points and used for subsequent analysis of new image sets (Fig 4.4). 
Because manual analysis of hundreds of images is time consuming, the 
WEKA classifier needed to be incorporated into a high-throughput analysis 
method. The analysis workflow into which it was incorporated is shown in Figure 
4.4. WEKA segmentation provided a much cleaner, closer segmentation of the 
mitochondria than conventional filtering and thresholding methods. The output of 
the classifier is a probability map: an image where the pixel intensity value 
represents the computer’s certainty from 0 to 1 that a specific pixel belongs to a 
certain class (in Figure 4.4, the “mitochondria” class is shown). This probability 
map can be manually or automatically thresholded for certainty level, but adding a 
manual step at this point ensures data quality with a human checkpoint evaluating 
the classifier output. 
When INS-1 cells were segmented with WEKA segmentation, the number 
of detected mitochondria increases twofold (Figure 5.4A). This increase is 
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attributable to the more accurate detection of background between proximal 
mitochondria compared to conventional thresholding, resulting in fewer 
mitochondria being combined when in fact they are discreet objects. As a result of 
the increased separation of mitochondria, mitochondrial perimeter is significantly 
decreased in WEKA-segmented measurements (Figure 5.4B). This decreased 
perimeter is the result of WEKA segmenting mitochondria while ignoring much of 
the airy fluorescent haze surrounding the mitochondria. As a consequence of this 
cleaner, closer segmentation, aspect ratio is increased (Figure 5.4C), circularity is 
decreased (Figure 5.4D), and solidity is decreased (Figure 5.4E). As an analogy, 
if outlining an object left a 1mm gap between the object and its outline, the object 
would be measured as being more round (circularity approaching 1, aspect ratio 
approaching 1, and solidity approaching 1). However, if the outline is more 
accurate and leaves only a 0.1mm gap between the object and the outline, the 
outline’s shape will more closely match the shape of the object, and its 
measurements would diverge from 1 because the object would be measured as 
less round. This increased accuracy of segmentation is illustrated in Figure 4.4 by 
comparing the traditionally thresholded image to the WEKA-segmented image. 
Detection of NE-induced mitochondrial fragmentation in BAT validated WEKA 
segmentation 
 BAT mitochondria fragment upon stimulation with NE (Wikstrom et al., 
2014).  Due to the obvious phenotype, this model was used to validate WEKA 
segmentation. WEKA segmentation was compared to the traditional thresholding 
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approach and to manual human segmentation of mitochondria by ROI drawing. 
While manual analysis exhibited the largest dynamic range and provided the most 
robust results (Fig 6.4), which is to be expected, traditional thresholding provided 
the least robust results – it is hampered by the background-increasing airy haze 
surrounding objects inherent to confocal microscopy. WEKA segmentation yielded 
significant decreases in mitochondrial connectivity (Circ and solidity), while also 
demonstrating a decreasing trend in AR upon fragmentation. This trend in AR is 
mitigated by an artifact inherent to the WEKA classifier included herein. Due to the 
inherent difficulty in mitochondrial segmentation, it splits larger objects into smaller 
ones, such as the very elongated filamentous mitochondria in nonstimulated BAT. 
However, this aggressive splitting is necessary to retain mitochondrial recognition, 
as evidenced by WEKA segmentation’s trend to detect more mitochondrial objects. 
While it may be possible to reduce the impact of this artifact by utilizing a BAT 
image training set rather than a mixed image training set, it would also decrease 
the flexibility of the classifier. Alternatively, due to the higher throughput of analysis 
enabled by the WEKA classifier and macro, larger sample sizes would also offset 
this artifact. 
DISCUSSION 
 Due to the increasing size (terabytes), quantity, and quality of data 
produced by digital microscopy in science, rapid, repeatable, and novel methods 
for processing these data are required. Given the difficulty of accurate image 
segmentation in service of unbiased measurements, we have created a novel 
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segmentation method to observe subpopulations of mitochondria within cells. 
Segmentation of images in creative ways provides additional granular approaches 
and resolution in existing and newly and formerly acquired images, providing 
additional ways to extract as much data as possible from micrographs. This 
peridroplet analysis methodology may be expanded by others to address similar 
hypotheses: for instance, are lysosomes near the nucleus distinct from those at 
the cell periphery? By adapting the above approach to dilate the nuclear region 
instead of a lipid region, such an investigation is possible. Such investigations are 
rare (Leonard et al., 2015), partly because light microscopes only recently 
achieved sufficient resolution to facilitate this type of analysis (Weisshart, 2014). 
While the biological implications of this ROS formation we discovered remains to 
be elucidated, a recent publication suggests that cytosolic mitochondria are more 
oxidative, while the peridroplet mitochondria are essential for lipid droplet formation 
(Benador et al., 2018). The increased ROS formation observed here suggests that 
the enhanced oxidative capacity comes at the cost of potential oxidative damage. 
Additionally, a novel machine learning segmentation method for mitochondria 
more accurately segments mitochondria than traditional methods. By combining 
this segmentation protocol with a high-throughput approach to image analysis, we 
have designed a workflow that expedites an unbiased analysis of mitochondrial 
parameters. These tools will not only enable more time-and cost- effective 
research, but also provide a platform from which other scientists may improve and 
build better analysis protocols. 
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Subcellular objects pose a unique challenge in advanced light microscopy, 
partly due to the refraction limit of light microscopes (Abbe, 1873). Some tools, 
including the Airyscan detector from Zeiss (Weisshart, 2014), provide novel ways 
to approach super resolution light microscopy and further enhance the quality of 
micrographs. With these improvements in imaging technology, image analysis is 
becoming more approachable and more necessary. While the above WEKA 
method largely utilized super resolution micrographs, the recognition of 
subpopulations of mitochondria was performed on images acquired without super 
resolution techniques. In fact, the WEKA classifier is sufficiently accurate to 
segment mitochondria from non-super resolution micrographs, as demonstrated in 
Fig. 4.4. Indeed, the images analyzed in Fig. 6.4 were not super-resolution images; 
WEKA segmentation accurately detected mitochondrial fragmentation from these 
images. However, no analysis is perfect, and the quality of input images can 
seriously hamper analysis. Other common issues and their simple solutions have 
been published recently by another group (Harwig et al., 2018). This provides a 
new tool to analyze and accurately quantify mitochondrial parameters from images 
of insufficient resolution to apply conventional thresholding techniques, again as 
illustrated in Fig. 4.4. This increased flexibility and accuracy will provide more 
robust analyses within the field going forward.
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Parameter Information Units Notes 
Fluorescence 
Intensity (FI) 
Brightness of 
fluorophore 
A.U. Can be sum or average of all 
intensity for entire region. 
Ratios of multiple 
fluorophores are possible 
Area (A) Cross-sectional 
area of region 
 Pixels 
(px), 
μm2 
 
Perimeter (P) Distance around 
region 
Pixels 
(px), 
μm 
 
Circularity 
(Circ) 
Branching 
4𝜋(𝐴𝑟𝑒𝑎) 
(𝑃𝑒𝑟𝑖𝑚𝑒𝑡𝑒𝑟)2
 
A.U. 0 <  𝐶𝑖𝑟𝑐 ≤  1; 
 Circ is 1 for a perfect circle; 
less than 1 for branched 
structures 
Circ = FF-1 
Form Factor 
(FF) 
Branching 
(𝑃𝑒𝑟𝑖𝑚𝑒𝑡𝑒𝑟)2 
4𝜋(𝐴𝑟𝑒𝑎)
 
A.U. 1 ≤ 𝐹𝐹 <  ∞; 
 FF is 1 for a perfect circle; 
more than 1 for branched 
structures 
FF = Circ-1 
Aspect Ratio 
(AR) 
Elongation 
𝐿𝑜𝑛𝑔 𝐴𝑥𝑖𝑠 
𝑆ℎ𝑜𝑟𝑡 𝐴𝑥𝑖𝑠
 
A.U. AR measures elongation, 
not branching 
Solidity Concavity 
𝑂𝑏𝑗𝑒𝑐𝑡 𝐴𝑟𝑒𝑎 
𝐶𝑜𝑛𝑣𝑒𝑥 𝐻𝑢𝑙𝑙 𝐴𝑟𝑒𝑎
 
A.U. Creates a fully convex shape 
(hull) surrounding the object 
and measures the ratio of 
the object area to the convex 
hull area 
 
Table 1.4. Common mitochondrial morphology parameters. 
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Figure 1.4. Schematic representation of quantification of peridroplet and 
cytosolic mitochondria in Brown Adipose Tissue.  
The original mutli-channel image is split into its component channels, which are 
then filtered for analysis. The lipid droplet is labeled with Nile Red dye, and this 
image region is used for recognition and segmentation throughout the analysis. 
The Nile red image is binarized and used multiple times in the analysis. First, it is 
used to subtract fluorescence bleed-through in the roGFP channel from the Nile 
Red. Then, the lipid droplet region is dilated n times, with n being empirically 
determined by the user to encompass peridroplet mitochondria. This dilated lipid 
region is then used to quantify the mitochondrial signal contained within. The 
cytosolic analysis builds on the previous steps, utilizing the dilated lipid region to 
remove any mitochondrial fluorescence in that region from the cytosolic image. 
The cytosolic image is then binarized, segmented, and measured similarly to the 
peridroplet image. Scale bar shown in original image is 10μm and is intentionally 
left out during analysis. Manual steps are outlined in red.
  102 
 
Figure 2.4. BAT mitochondria produce different amounts of H2O2 depending 
on their localization in relation to lipid droplets.  
BAT cytosolic mitochondria (CM) produce significantly more H2O2 than their 
peridroplet (PDM) counterparts. Addition of menadione increased ROS production 
significantly in both mitochondrial populations. 
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Figure 3.4. Representation of iterative training of the machine learning 
classifier using the WEKA trainable segmentation plugin for FIJI.  
Once an image is opened in FIJI, WEKA trainable segmentation can be called from 
the plugins menu. WEKA is capable of using several machine learning algorithms, 
with the most fitting being FastRandomForest considering time and processor 
utilization. Options set within the WEKA GUI can control the parameters used for 
machine learning, though several of these require additional plugins. Once open, 
the user defines the number and name of each class of object. Once the classes 
are defined, the user can use any selection tool available in FIJI (line, rectangle, 
circle, etc.) to define what image objects belong to which class. Upon clicking “train 
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classifier,” the computer then calculates the best segmentation algorithm and 
returns a map of the classes overlaid over the training image which can be used 
to refine the class segmentation with subsequent rounds of assignment and 
training. Once WEKA returns a satisfactory segmentation of the image, the user 
can finalize the classifier to be used on new data sets. Scale bar shown in original 
image is 10μm and is intentionally left out during analysis. Manual steps are 
outlined in red.  
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Figure 4.4. Workflow for a WEKA-based mitochondrial segmentation and 
analysis.  
The original image is initially filtered to remove uneven background using the 
rolling ball algorithm with a diameter of 50 pixels. This facilitates better recognition 
of mitochondria by the WEKA classifier. Shown at this branch point for comparison 
is traditional threshold-based segmentation of mitochondria in the same image. 
Once the image is classified with the WEKA classifier, it returns a probability map. 
A probability map is the algorithm’s best guess at which class each pixel in an 
image belongs to, in this case mitochondria or background, with a probability from 
0 to 1. The user manually thresholds the certainty of the classification for best 
mitochondrial segmentation (though this step may be automated with validation). 
After the thresholding step, the image is binarized, the mitochondrial objects 
segmented for measurement, and then measured. Scale bar shown in original 
image is 10μm and is intentionally left out during analysis. Manual steps are 
outlined in red.  
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Figure 5.4. Comparison of mitochondrial morphological measurements 
segmented with WEKA segmentation versus traditional thresholding.  
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WEKA segmentation is significantly better at recognizing, separating, and 
quantifying individual mitochondria (A). Because of this more accurate 
segmentation, the mitochondrion is measured much more closely to its actual 
boundaries instead of the airy haze surrounding it. As a result, the Perimeter 
readout is significantly reduced (B). This more accurate segmentation provides 
more accurate measurements of Aspect Ratio (C), Circularity (D), and Solidity (E), 
and cross-sectional area (F). Better object recognition leads to improved dynamic 
range of measurements. Each point represents an individual image, error bars 
SEM. * p≤0.05 by t-test. 
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Fig 6.4. WEKA segmentation detects mitochondrial fragmentation in NE-
activated BAT  
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A clear trend was exhibited by traditional thresholding to detect fewer mitochondrial 
objects per cell due to background fluorescence and airy haze surrounding 
mitochondrial objects in the images (A). WEKA segmentation detected significantly 
more mitochondrial objects than traditional thresholding but was not significantly 
different from manual ROI creation. The WEKA classifier more aggressively splits 
long filaments than a human analyst, leading to a trend of increased mitochondrial 
objects in the basal (nonstimulated) condition compared to manual analysis (A). 
This largely unavoidable bias is also evidenced by the significant decrease of AR 
with WEKA segmentation when compared to manual analysis (B). This artifact 
inherent to the algorithm necessitates a larger sample size for observed trends to 
be significant. However, Circ (C) and Solidity (D) exhibit significant increases with 
NE-activation of brown fat, suggesting reduced mitochondrial connectivity upon 
activation and validating the WEKA-based segmentation approach. WEKA 
segmentation increases dynamic range of measurements in both circularity and 
AR, error not shown because dynamic range was calculated from the averages 
shown in panels (A)-(D). (E) Each bar is the mean of >10 cells per condition from 
3 separate experiments with error bars representing SEM; p≤0.05 by one-way 
ANOVA: (*) significant difference between basal vs NE conditions of same analysis 
method; (@) significant difference vs threshold analysis of same condition; (#) 
significant difference vs WEKA analysis of same condition; ($) significant 
difference vs manual analysis of same condition. 
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CHAPTER FIVE: General Discussion 
Hyperinsulinemia as an initiating factor in T2D 
Type 2 diabetes is a chronic disease affecting an increasing number of 
people worldwide. Its financial burden on society and its patients will increase 
accordingly. Genome wide associated studies have implicated β-cell dysfunction 
in the development of diabetes. Indeed, the vast majority of genes associated with 
diabetes are related to β-cells and insulin secretion (Lim et al., 2011). Historically, 
T2D has been considered a disease of insulin resistance which is ill-compensated 
for and results in eventual β-cell death. However, mounting evidence suggests that 
hyperinsulinemia can precede insulin resistance. Resolution of hyperinsulinemia 
is rapid following gastric bypass surgery, and this procedure remains the only 
curative treatment for T2D (Lim et al., 2011; Reed et al., 2011). Because of the 
inherently related nature of these phenomena and their downstream effects, their 
exact contribution to disease progression is difficult to decipher. Islets typically 
secrete insulin in a pulsatile manner (Cunningham et al., 1996; Porksen et al., 
2002), which mirrors Ca2+ oscillations (Deeney et al., 2001), which in turn mirror 
metabolic oscillations in glycolysis (Tornheim, 1997), all with periods of 5-10 
minutes. One of the earliest hallmarks of disease is loss of the oscillatory behavior 
of insulin secretion. Hyperinsulinemia, loss of phase II oscillations, and increased 
insulin secretion in response to fatty acids are thought to contribute to the 
development of T2D, but the relationship between mitochondrial morphology and 
these phenotypes remains to be elucidated.  
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Investigation of non-glucose-stimulated insulin secretion revealed novel 
roles for mitochondrial morphology in FFA metabolism 
Within this thesis, I have demonstrated that Mfn2 regulates insulin secretion 
in islets, particularly at substimulatory glucose concentrations and in response to 
FFA (Chapter 2). Other work has suggested obesity leads to increased sensitivity 
to FFA-induced insulin secretion, which has profound implications for the study of 
diabetes development (C J Nolan et al., 2006). The increased sensitivity to fatty 
acid induced insulin secretion could be a key progression toward T2D, because 
hyperlipidemia is often associated with obesity in humans. We investigated several 
possible mechanisms for the increased sensitivity to FFA, in addition to expanding 
our work to established cell lines and exhaustively investigating their suitability as 
a model for the reduction of Mfn2 in primary β-cells (Chapter 3). Finally, we provide 
novel methods to quantify high-resolution micrographs and the structure of 
subcellular structures in brown adipocytes (Chapter 4). Future directions include 
pursuit of the mechanism by which mitochondrial fragmentation induces increased 
nonstimulated insulin secretion and FFA-induced insulin secretion. Additionally, 
investigation of the lack of effects in a knockdown model of Mfn2 in INS-1 cells and 
significant impairment with knockout of Mfn2 in primary tissue may yield new 
regulatory mechanisms of metabolism and mitochondrial morphology, as well as 
offer a way to tease apart the role of Mfn2 in each phenomenon. Revealing the 
Mfn2-specific roles of fragmentation versus its metabolic regulation is a burning 
question in the field: does morphology govern fuel preference, or vice versa? Is 
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morphology a readout of the metabolic effects of Mfn2 downregulation? Future 
experiments should utilize recent tool peptides developed by other labs to dissect 
the contribution of each Mfn2 activity to the phenotype (Franco et al., 2016). These 
peptides are capable of manipulating mitochondrial morphology independent of 
other regulatory effects of Mfn2, providing an ideal manipulation to investigate the 
interplay of morphology and metabolic regulation. 
By utilizing existing tools such as FIJI and trainable WEKA segmentation, 
we created a method to segment BAT that provides a previously unstudied 
granularity to mitochondrial measurements, which may help answer these 
questions, particularly in light of the recent work demonstrating ATP synthesis and 
respiromentric differences between these same subsets of mitochondria (Benador 
et al., 2018). Finally, building on the existing machine-learning classifier and 
applying it to additional subcellular structures will potentially provide rapid and 
robust image segmentation and quantification. Indeed, combining the peridroplet 
versus cytosolic mitochondria segmentation method with the machine learning 
segmentation of mitochondria could provide the most accurate, granular approach 
to mitochondrial quantification yet. 
In chapter 2, we show that mitochondrial fragmentation is induced by 
excess nutrients through downregulation of Mfn2, building on previous work from 
our lab and others showing mitochondrial fragmentation in response to excess 
nutrient challenge (Molina et al., 2009). Other labs have shown a decrease in Mfn2 
expression in models of obesity in muscle and adipose (Bach et al., 2003; Le Blanc 
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et al., 2012; Pich et al., 2005; Sorianello et al., 2012). In an effort to dissect the 
role of mitochondrial morphology in the obese condition, we forced the 
fragmentation of mitochondria by knocking out Mfn2 in primary pancreatic β-cells 
via the loxp-Cre system. Genetic ablation of Mfn2 in mice resulted in increased 
basal insulin secretion without change in insulin content. This increased insulin 
secretion is in part due to an increase in FFA-induced insulin secretion, mirroring 
previous results from other labs studying Zucker fatty rats (C J Nolan et al., 2006). 
At the same time, Knockout of Mfn2 resulted in increased oxygen consumption in 
response to FFA in the media. Taken together, the forced fragmentation of 
mitochondria elicited a shift at basal glucose concentrations to FFA for oxidation 
and insulin secretion. Not only did Mfn2-KD cells exhibit greater uptake of FFA, but 
they also oxidized more palmitate when provided palmitate as the primary fuel. 
Consistent with this observation, loss of Mfn2 resulted in increased FFA oxidation 
and uptake in INS-1 cells with Mfn2KD. This phenotype suggests an important role 
for FFA metabolism in β-cells and insulin secretion.  
Mechanistic explorations of β-Mfn2KO phenotype point to fatty acids as playing a 
pivotal role 
In an effort to determine the mechanism for insulin secretion induction by 
this fuel switch, we investigated several regulators of insulin secretion. We initially 
investigated the role of intracellular Ca2+ using the Fura-2 ratiometric probe 
because it plays an important role in triggering of insulin secretion by inducing 
exocytosis of insulin granules. We found that intracellular calcium was unchanged 
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at basal glucose in Mfn2KO islets and sought another possible explanation. ROS, 
specifically H2O2, has been demonstrated to be an insulin secretagogue (Saadeh 
et al., 2012), as well as the ratio of the endogenous antioxidant glutathione playing 
a role in insulin secretion (Ferdaoussi et al., 2015). However, H2O2 production was 
not altered by the loss of Mfn2. Other regulators of FFA metabolism remain to be 
investigated, such as CPT-1, the primary control point of FFA oxidation in the 
mitochondria. 
Other processes also affect FFA-induced insulin secretion. For instance, 
the Prentki group has suggested a role for a futile cycle of lipolysis and 
reesterification which modulates intracellular concentrations of the intermediates 
of fatty acid metabolism, such as MAG, DAG, and LC-CoA, which have been 
shown to modulate insulin secretion in vitro (Kwan et al., 2006; Roduit et al., 2004; 
Saadeh et al., 2012). These intermediates can act intracellularly in the case of 
DAG on SNARE-mediated exocytosis of insulin granules (Kwan et al., 2006; Marc 
Prentki et al., 2013), or extracellularly at membrane FFA receptors, particularly 
GPR40, which has been implicated in insulin secretion (El-Azzouny et al., 2014; 
Latour et al., 2007). Taken together, the link between fatty acid metabolism and 
insulin secretion may play a pivotal role in the physiology of T2D, because obese 
subjects often have significantly elevated circulating triglyceride (Seigneur et al., 
1994). However, deletion of Mfn2 in BAT increased mitochondrial FAO coupled to 
ATP production (Mahdaviani et al., 2017), the production of which in β-cells could 
also trigger the GSIS pathway via an increase in ATP/ADP ratio. While acute 
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exposure to FFA potentiates insulin secretion (Branstrom et al., 1997; El-Azzouny 
et al., 2014; Y.-P. Zhou & Grill, 1995; Y. Zhou & Grill, 1994), chronic exposure to 
FFA blunts GSIS (Carlsson et al., 1999), and chronic nutrient excess leads to 
accumulation of intracellular lipid that causes β-cells to secrete insulin at lower 
levels of glucose (Erion et al., 2015). 
The characteristic position of the β-cell as a fuel signal integrator provides 
promise for novel drug targets. Inhibitors of lipolysis such as orlistat have 
demonstrated a role for this process in insulin secretion (Attané et al., 2016; Peyot 
et al., 2004; Zhao et al., 2014). FAO, likewise, is necessary for GSIS and can be 
inhibited via etomoxir (Rubí et al., 2002; Sako & Grill, 1990). New therapeutics 
such as small peptide inhibitors of the Drp1-Fis1 mitochondrial fission inducing 
interaction may be promising as inhibitors of mitochondrial fragmentation in 
pathological conditions, halting morphological changes prior to appearance of 
deleterious downstream effects. (Kim et al., 2015; Qi, Qvit, Su, & Mochly-Rosen, 
2013). 
Metabolic implications of inhibition of mitochondrial fusion 
Studying the pancreatic β-cell poses unique challenges due to the low yield 
from isolation of islets from pancreases, and as such is amenable to use of cell 
lines. In chapter 3, we knocked down Mfn2 in a commonly-used β-cell line, INS-1 
cells and investigated the effects of this manipulation. This adenovirally-delivered 
shRNA reduced the expression of Mfn2 in INS-1 cells and contributed to an 
increase in FFA uptake. Additionally, the Mfn2-KD cells exhibited decreased 
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maximal respiratory capacity and other defects not seen in primary cell models 
included in chapter 2 but consistent with other publications also using adenovirally-
delivered shRNA for Mfn2KD in HeLa cells (Ding et al., 2015), suggesting a 
possible inhibition of autophagy that increased the proportion of dysfunctional 
mitochondria. Autophagic defects in β-cells contribute to the development of 
diabetes in rodents (Quan et al., 2012). Our lab previously demonstrated that 
rescue of autophagic flux improved insulin secretion in excess nutrient 
environments (Trudeau et al., 2016). However, insulin secretion was unaffected by 
Mfn2KD in INS-1 cells, suggesting this inhibition of autophagy was either absent 
or had not manifest in the time scales investigated. Because the primary functional 
readout of β-cells is insulin secretion, the lack of defect in this model suggested 
that Mfn2KD in INS-1 cells does not recapitulate the phenotype of Mfn2KO primary 
islets, posing a significant challenge to using this model to study the mechanisms 
of fuel preference switch.  
Β-Mfn2KO vs Mfn2-KD models may expose regulatory differences or protein half 
life 
The differences between the INS1-KD and the primary tissue KO systems 
can be due to several possible mechanisms. First, cell lines and primary cells are 
inherently different, with cell lines being immortalized. Regardless, INS-1 cells 
serve as a common model of β-cells, and findings therefrom have contributed 
immensely to the field (Brun, Assimacopoulos-Jeannet, Corkey, & Prentki, 1997; 
Cerqueira et al., 2016; Erion et al., 2015; Lablanche et al., 2011; Molina et al., 
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2009; Rubí et al., 2002; Skelin et al., 2010; Twig et al., 2008).  One possible 
explanation for the mild phenotype in INS-1 Mfn2-KD cells is the timing of 
knockdown and knockout (72 hours). While the half-life of Mfn2 is not known, 
perhaps the KD of Mfn2 was assayed too early in the defect (72 hours, peak 
expression of shRNA from adenovirus).  Additionally, truncated Mfn2 lacking fusion 
activity is capable of stimulating ETC activity in muscle (Pich et al., 2005), 
suggesting that Mfn2 may have been present at a sufficient level to maintain 
metabolism even in the face of overt fragmentation shown in chapter 2. Perhaps 
the ~60% knockdown of Mfn2 was sufficient to induce fragmentation but not 
metabolic defects in INS-1 cells. This hypothesis can be addressed by generating 
an Mfn2-KO INS-1 cell line, which is an active area of development in our lab. Yet 
another explanation for the difference between these two systems could stem from 
the AAV vector used to deliver the shRNA. While both models utilized AAV vectors 
to deliver the manipulation of Mfn2, the different active titers of the vectors could 
contribute to additional stress in the INS-1 cells, which required almost twice as 
many viral particles per cell for efficient transduction of KD of Mfn2.  
Novel segmentation protocol of mitochondria in BAT provides granular, 
rapid, and robust analysis 
Because of modern high-throughput data acquisition tools, such as the 
Operetta High Content imager, and automation of low-throughput tools like the 
Zeiss LSM 880, the quantity and quality of imaging data available for analysis is 
steadily increasing. With this proverbial firehose of data comes the need to distill it 
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down into its meaningful components. Less modern programming and statistical 
tools such as R provide ways to handle and manipulate the data once quantified, 
but quantification of these images is the major bridge left to be constructed in the 
analysis workflow.  
 Image analysis is a complex and growing field, providing rich opportunities 
for new and exciting discoveries, even from data acquired years previously. The 
customizable and broad program ImageJ and its plugin-rich fork FIJI (Schindelin 
et al., 2012) provide the basis for transparent and repeatable image analysis, while 
specific plugins provide the same promise to more specialized analyses. By 
utilizing these plugins, we are able to construct a rapid, transparent, and 
repeatable segmentation of mitochondria from high quality micrographs, in 
addition to segmentation of subcellular regions necessary for quantifying 
differences within a cell, such as peridroplet vs. cytosolic mitochondria and their 
differing H2O2 production (Ch. 4). Novel segmentation of images provides an 
opportunity to extract additional data from existing images, and can even illuminate 
new biology, as in the case of peridroplet and cytosolic BAT mitochondria (Benador 
et al., 2018), complementing more traditional biochemical approaches and 
isolation techniques such as mitochondrial isolation, respirometry, and western 
blotting.  
Many other labs have provided methods for measuring mitochondrial 
parameters, but some bin by morphological characteristics using machine learning 
instead of outright quantification (Leonard et al., 2015), and some utilize traditional 
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segmentation methods such as filtering and thresholding (Joshi et al., 2000; Molina 
et al., 2009; Wiemerslage & Lee, 2016). To our knowledge, no lab has utilized a 
machine-learning approach to segment mitochondria to subsequently quantify. 
Here, we provide a machine learning classifier capable of separating and 
segmenting mitochondria that previously were difficult or even impossible to 
segment with traditional methods due to image quality, contrast, and fluorescence 
intensity complications. By utilizing machine learning in this new way, we have 
demonstrated its current and future value, though it requires an analysis computer 
with significant processing power and RAM. However, the input images this 
segmentation protocol is capable of processing is more diverse than traditional 
methods and includes lower-resolution (i.e. 512 x 512) images, providing a flexible 
tool for mitochondrial scientists.  
Broader implications of the thesis and future directions 
Mitochondrial dynamics may play a role in T2D and hyperlipidemia 
The elucidation of mitochondrial dynamics and the lifecycle of mitochondria 
has had profound impacts on the study of metabolism (Liesa & Shirihai, 2013). 
From Alzheimer’s to cancer to T2D, mitochondria play an important role in 
deranged metabolism and dysfunction. Single mutated proteins are capable of 
causing disease, such as Optic Atrophy (Opa1) and Charcot-Marie Tooth Disease 
Type IIa (Mfn2). Recent developments in sample throughput have increased the 
amount of data collected per each experiment, and the tools to analyze this large 
amount of data are still nascent and are actively being developed. Dissecting the 
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role of specific mitochondrial dynamics events, such as fusion, fission, mitophagy, 
and biogenesis have provided novel insights into disease mechanisms (Boutant et 
al., 2017; Dagda et al., 2009; Frank, 2006; Hiller & Metallo, 2013; Mahdaviani et 
al., 2017; Nguyen et al., 2016; Qi et al., 2013; Rocha et al., 2017). With these 
insights has come identification of novel regulatory mechanisms, such as 
autophagy (Trudeau et al., 2016), fuel preference (Mahdaviani et al., 2017), and 
uncoupled respiration (Ježek et al., 2014). Adding to this body of work, I have 
shown that mitochondrial fragmentation itself is capable of increasing insulin 
secretion in response to FFA while disrupting the normal pattern of insulin 
secretion. Not only does the increased sensitivity to palmitate reinforce the 
importance of hyperlipidemia in the obese patient, but also provides a potential 
mechanism to target for treatment. These findings may have implications in other 
cells types, where the regulation of mitochondrial fusion has functional 
consequences (Boutant et al., 2017; Mahdaviani et al., 2017). Indeed, if 
mitochondrial fuel preference is controlled by morphology, morphology presents 
an entirely new therapeutic target for a host of diseases, such as ALS (Qi et al., 
2013), obesity (Mahdaviani et al., 2017), and several neurological defects (H. Chen 
& Chan, 2005; H. Chen et al., 2007; Wiemerslage & Lee, 2016).  
One appealing hypothesis for the switch in fuel preference centers on CPT-
1 and its rate-limiting control of mitochondrial FA oxidation. CPT-1 is expressed in 
β-cells (Assimacopoulos-Jeannet et al., 1997) and controls the entry of fatty acids 
conjugated to carnitine into mitochondria, and as such is tightly regulated by its 
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endogenous inhibitor and product of glucose metabolism, Malonyl-CoA (McGarry, 
Mannaerts, & Foster, 1977; Newgard & McGarry, 1995). CPT-1 sensitivity to Mal-
CoA is modulated by several factors, including membrane fluidity, and 
mitochondrial membrane fluidity is increased in the livers of high-fat diet fed Wistar 
rats (Aoun et al., 2012), a condition shown to decrease CPT-1 sensitivity to 
inhibition by Mal-CoA (Faye et al., 2005). Conceivably, this release of inhibition on 
CPT-1 would increase FA oxidation in the face of excess nutrients, which would 
be consistent with compensatory behavior to this environment attempting to 
detoxify the excess lipids. However, this compensation could become pathological 
if it induced increased insulin secretion at a non-stimulatory glucose concentration, 
contributing to hyperinsulinemia prior to insulin resistance. Because mitochondrial 
fragmentation is observed in high-fat diet fed animals, mitochondrial membrane 
fluidity presents an attractive target to study the control of fuel preference. 
Further investigation of the role of mitochondrial morphology on β-cell 
function holds promise to understand the mechanism of development of T2D. 
While I have not discovered the mechanism of basal hypersecretion of insulin here, 
I have tested several viable hypotheses and can tentatively exclude H2O2 and Ca2+ 
from the pathway. Indeed, the evaluation of H2O2 production in Mfn2KO islets 
presents a stronger case than previous studies due to the reversible nature of the 
probe used and minimum and maximum normalization every experiment (Morgan 
et al., 2011). This approach provides clear benefits over commonly-used ROS 
probes such as DHE, which is both irreversible and prone to artifacts that hamper 
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interpretation of the data (Fink et al., 2004; Laurindo et al., 2008; Nazarewicz et 
al., 2013; Tollefson et al., 2003). DHE, however, can be further analyzed using 
HPLC to separate its oxidation products and decode what ROS oxidized the probe 
(Laurindo et al., 2008). However, these findings still point to a possible 
phenomenon wherein mitochondrial morphology governs fuel preference. Several 
lines of evidence support this hypothesis, including the different specializations 
between cytosolic and peridroplet mitochondria in BAT (Benador et al., 2018), the 
increased FFA utilization in β-cells (Ch. 2), and the changes in mitochondrial 
morphology during overfeeding and starvation (Liesa & Shirihai, 2013). This may 
represent a basic eukaryotic regulatory system – one which remains to be fully 
investigated and manipulated. Even in cells lacking a functional outcome from 
forced mitochondrial fragmentation, fuel preference and FFA uptake is altered (Ch. 
3). In hepatocytes, mitochondrial morphology is governed by fuel environment as 
well, which can be counteracted by upregulation of Mfn2 (Zhang, Jiang, Hu, Zheng, 
& Xiang, 2011). 
New analysis methods provide data to complement other biochemical methods 
Measurement of mitochondrial parameters presents unique challenges 
related to their size and physiological environment. Isolated mitochondria must be 
maintained in the proper osmotic environment and with appropriate nutrients 
generally found in the cytoplasm. Even then, mitochondria lose their distinct 
morphological characteristics when removed from the cytoplasm and cytoskeleton. 
Measuring mitochondria in intact cells poses challenges – primarily related to size 
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and nutrient availability. Not only do mitochondria require a high-resolution high-
magnification microscope to visualize, but they also must be separated from one 
another in order to measure. Within a cell body, this is no small task. Expressly 
because of these challenges, I have provided novel analysis methods to extract 
data from high-resolution micrographs. Protocols like the novel segmentation 
described herein provide powerful and flexible tools to speed and assist the 
mitochondrial scientist with these issues. The approaches described herein are 
complementary and can be combined to provide extremely granular data 
describing mitochondria within living cells. 
Not only do analysis protocols like those contained herein provide rapid and 
robust analysis, but they can be further developed to facilitate workflow 
management. Some programs exist to manage the entire workflow from data 
collection to analysis, such as the Harmony software from Perkin Elmer. Not only 
does Harmony automate image acquisition, but it facilitates construction of (albeit 
limited) analysis macros. Potential exists for combining disparate softwares from 
various manufacturers to manage workflow and expedite analysis. For this reason, 
analysis protocols contained in this thesis are built in an open-source platform for 
maximal cross-platform performance. By maximizing flexibility and transparency in 
the analysis workflow, these tools are made available to the widest audience.  
Conclusion 
The long-term goal of this research is to elucidate the role of mitochondrial 
morphology and function in the development of T2D and find ways to prevent or 
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reverse disease progression. We have provided evidence demonstrating that 
mitochondrial morphology is governed by the nutrient environment and may 
underlie compensatory or pathological changes in metabolism and have provided 
novel ways to quantify the role of mitochondria in these models. Multiple tissues 
are involved in T2D, and many show similar mitochondrial behavior in response to 
similar stimuli. Thus, this work explored what may be an ancient regulatory 
mechanism responsible for nutrient induced stress. Further research is needed to 
understand the nature of this regulation and its implications for β-cell function 
specifically and T2D more broadly.  
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